id	sid	tid	token	lemma	pos
iajs-3516	1	1	1	1	NUM
iajs-3516	1	2	©	©	ADP
iajs-3516	1	3	2025	2025	NUM
iajs-3516	1	4	the	the	DET
iajs-3516	1	5	author(s	author(s	NOUN
iajs-3516	1	6	)	)	PUNCT
iajs-3516	1	7	.	.	PUNCT
iajs-3516	2	1	published	publish	VERB
iajs-3516	2	2	by	by	ADP
iajs-3516	2	3	college	college	NOUN
iajs-3516	2	4	of	of	ADP
iajs-3516	2	5	education	education	NOUN
iajs-3516	2	6	for	for	ADP
iajs-3516	2	7	pure	pure	ADJ
iajs-3516	2	8	science	science	NOUN
iajs-3516	2	9	(	(	PUNCT
iajs-3516	2	10	ibn	ibn	PROPN
iajs-3516	2	11	al	al	PROPN
iajs-3516	2	12	-	-	PUNCT
iajs-3516	2	13	haitham	haitham	PROPN
iajs-3516	2	14	)	)	PUNCT
iajs-3516	2	15	,	,	PUNCT
iajs-3516	2	16	university	university	NOUN
iajs-3516	2	17	of	of	ADP
iajs-3516	2	18	baghdad	baghdad	PROPN
iajs-3516	2	19	.	.	PUNCT
iajs-3516	3	1	this	this	PRON
iajs-3516	3	2	is	be	AUX
iajs-3516	3	3	an	an	DET
iajs-3516	3	4	open	open	ADJ
iajs-3516	3	5	-	-	PUNCT
iajs-3516	3	6	access	access	NOUN
iajs-3516	3	7	article	article	NOUN
iajs-3516	3	8	distributed	distribute	VERB
iajs-3516	3	9	under	under	ADP
iajs-3516	3	10	the	the	DET
iajs-3516	3	11	terms	term	NOUN
iajs-3516	3	12	of	of	ADP
iajs-3516	3	13	the	the	DET
iajs-3516	3	14	creative	creative	ADJ
iajs-3516	3	15	commons	common	NOUN
iajs-3516	3	16	attribution	attribution	NOUN
iajs-3516	3	17	4.0	4.0	NUM
iajs-3516	3	18	international	international	ADJ
iajs-3516	3	19	license	license	NOUN
iajs-3516	3	20	immunological	immunological	ADJ
iajs-3516	3	21	prevalence	prevalence	NOUN
iajs-3516	3	22	of	of	ADP
iajs-3516	3	23	ebv	ebv	NOUN
iajs-3516	3	24	in	in	ADP
iajs-3516	3	25	rheumatoid	rheumatoid	NOUN
iajs-3516	3	26	arthritis	arthritis	NOUN
iajs-3516	3	27	iraqi	iraqi	ADJ
iajs-3516	3	28	patients	patient	NOUN
iajs-3516	3	29	wafaa	wafaa	PROPN
iajs-3516	3	30	ayad	ayad	PROPN
iajs-3516	3	31	al	al	PROPN
iajs-3516	3	32	-	-	PUNCT
iajs-3516	3	33	nuaimy	nuaimy	PROPN
iajs-3516	3	34	1	1	NUM
iajs-3516	3	35	*	*	PUNCT
iajs-3516	3	36	and	and	CCONJ
iajs-3516	3	37	dunya	dunya	PROPN
iajs-3516	3	38	fareed	fareed	PROPN
iajs-3516	3	39	salloom	salloom	NOUN
iajs-3516	3	40	2	2	NUM
iajs-3516	3	41	1,2	1,2	NUM
iajs-3516	3	42	department	department	NOUN
iajs-3516	3	43	of	of	ADP
iajs-3516	3	44	biology	biology	NOUN
iajs-3516	3	45	,	,	PUNCT
iajs-3516	3	46	college	college	NOUN
iajs-3516	3	47	of	of	ADP
iajs-3516	3	48	science	science	NOUN
iajs-3516	3	49	,	,	PUNCT
iajs-3516	3	50	university	university	NOUN
iajs-3516	3	51	of	of	ADP
iajs-3516	3	52	baghdad	baghdad	PROPN
iajs-3516	3	53	,	,	PUNCT
iajs-3516	3	54	baghdad	baghdad	PROPN
iajs-3516	3	55	,	,	PUNCT
iajs-3516	3	56	iraq	iraq	PROPN
iajs-3516	3	57	.	.	PUNCT
iajs-3516	4	1	*	*	PUNCT
iajs-3516	4	2	corresponding	correspond	VERB
iajs-3516	4	3	author	author	NOUN
iajs-3516	4	4	.	.	PUNCT
iajs-3516	5	1	received	receive	VERB
iajs-3516	5	2	:	:	PUNCT
iajs-3516	5	3	22	22	NUM
iajs-3516	5	4	may	may	PROPN
iajs-3516	5	5	2023	2023	NUM
iajs-3516	5	6	accepted	accept	VERB
iajs-3516	5	7	:	:	PUNCT
iajs-3516	5	8	6	6	NUM
iajs-3516	5	9	august	august	PROPN
iajs-3516	5	10	2023	2023	NUM
iajs-3516	5	11	published	publish	VERB
iajs-3516	5	12	:	:	PUNCT
iajs-3516	5	13	20	20	NUM
iajs-3516	5	14	july	july	NOUN
iajs-3516	5	15	2025	2025	NUM
iajs-3516	5	16	doi.org/10.30526/38.3.3516	doi.org/10.30526/38.3.3516	NOUN
iajs-3516	5	17	abstract	abstract	ADV
iajs-3516	5	18	it	it	PRON
iajs-3516	5	19	has	have	AUX
iajs-3516	5	20	been	be	AUX
iajs-3516	5	21	hypothesized	hypothesize	VERB
iajs-3516	5	22	that	that	SCONJ
iajs-3516	5	23	infection	infection	NOUN
iajs-3516	5	24	with	with	ADP
iajs-3516	5	25	the	the	DET
iajs-3516	5	26	epstein	epstein	PROPN
iajs-3516	5	27	-	-	PUNCT
iajs-3516	5	28	barr	barr	PROPN
iajs-3516	5	29	virus	virus	PROPN
iajs-3516	5	30	(	(	PUNCT
iajs-3516	5	31	ebv	ebv	NOUN
iajs-3516	5	32	)	)	PUNCT
iajs-3516	5	33	may	may	AUX
iajs-3516	5	34	play	play	VERB
iajs-3516	5	35	a	a	DET
iajs-3516	5	36	role	role	NOUN
iajs-3516	5	37	in	in	ADP
iajs-3516	5	38	the	the	DET
iajs-3516	5	39	development	development	NOUN
iajs-3516	5	40	of	of	ADP
iajs-3516	5	41	autoimmune	autoimmune	ADJ
iajs-3516	5	42	illnesses	illness	NOUN
iajs-3516	5	43	,	,	PUNCT
iajs-3516	5	44	including	include	VERB
iajs-3516	5	45	rheumatoid	rheumatoid	NOUN
iajs-3516	5	46	arthritis	arthritis	NOUN
iajs-3516	5	47	(	(	PUNCT
iajs-3516	5	48	ra	ra	NOUN
iajs-3516	5	49	)	)	PUNCT
iajs-3516	5	50	.	.	PUNCT
iajs-3516	6	1	this	this	DET
iajs-3516	6	2	study	study	NOUN
iajs-3516	6	3	aimed	aim	VERB
iajs-3516	6	4	to	to	PART
iajs-3516	6	5	investigate	investigate	VERB
iajs-3516	6	6	whether	whether	SCONJ
iajs-3516	6	7	or	or	CCONJ
iajs-3516	6	8	not	not	PART
iajs-3516	6	9	a	a	DET
iajs-3516	6	10	history	history	NOUN
iajs-3516	6	11	of	of	ADP
iajs-3516	6	12	infection	infection	NOUN
iajs-3516	6	13	with	with	ADP
iajs-3516	6	14	the	the	DET
iajs-3516	6	15	virus	virus	NOUN
iajs-3516	6	16	is	be	AUX
iajs-3516	6	17	more	more	ADV
iajs-3516	6	18	common	common	ADJ
iajs-3516	6	19	in	in	ADP
iajs-3516	6	20	ra	ra	PROPN
iajs-3516	6	21	patients	patient	NOUN
iajs-3516	6	22	compared	compare	VERB
iajs-3516	6	23	to	to	ADP
iajs-3516	6	24	controls	control	NOUN
iajs-3516	6	25	.	.	PUNCT
iajs-3516	7	1	ninety	ninety	NUM
iajs-3516	7	2	samples	sample	NOUN
iajs-3516	7	3	ranging	range	VERB
iajs-3516	7	4	from	from	ADP
iajs-3516	7	5	20	20	NUM
iajs-3516	7	6	to	to	PART
iajs-3516	7	7	70	70	NUM
iajs-3516	7	8	years	year	NOUN
iajs-3516	7	9	old	old	ADJ
iajs-3516	7	10	were	be	AUX
iajs-3516	7	11	obtained	obtain	VERB
iajs-3516	7	12	(	(	PUNCT
iajs-3516	7	13	45	45	NUM
iajs-3516	7	14	patients	patient	NOUN
iajs-3516	7	15	plus	plus	CCONJ
iajs-3516	7	16	45	45	NUM
iajs-3516	7	17	controls	control	NOUN
iajs-3516	7	18	)	)	PUNCT
iajs-3516	7	19	between	between	ADP
iajs-3516	7	20	october	october	PROPN
iajs-3516	7	21	2022	2022	NUM
iajs-3516	7	22	and	and	CCONJ
iajs-3516	7	23	march	march	PROPN
iajs-3516	7	24	2023	2023	NUM
iajs-3516	7	25	;	;	PUNCT
iajs-3516	7	26	each	each	DET
iajs-3516	7	27	group	group	NOUN
iajs-3516	7	28	included	include	VERB
iajs-3516	7	29	37	37	NUM
iajs-3516	7	30	females	female	NOUN
iajs-3516	7	31	and	and	CCONJ
iajs-3516	7	32	8	8	NUM
iajs-3516	7	33	males	male	NOUN
iajs-3516	7	34	.	.	PUNCT
iajs-3516	8	1	rheumatoid	rheumatoid	VERB
iajs-3516	8	2	arthritis	arthritis	NOUN
iajs-3516	8	3	(	(	PUNCT
iajs-3516	8	4	ra	ra	NOUN
iajs-3516	8	5	)	)	PUNCT
iajs-3516	8	6	patients	patient	NOUN
iajs-3516	8	7	who	who	PRON
iajs-3516	8	8	were	be	AUX
iajs-3516	8	9	chosen	choose	VERB
iajs-3516	8	10	for	for	ADP
iajs-3516	8	11	this	this	DET
iajs-3516	8	12	study	study	NOUN
iajs-3516	8	13	were	be	AUX
iajs-3516	8	14	sent	send	VERB
iajs-3516	8	15	with	with	ADP
iajs-3516	8	16	a	a	DET
iajs-3516	8	17	physician	physician	NOUN
iajs-3516	8	18	report	report	NOUN
iajs-3516	8	19	for	for	ADP
iajs-3516	8	20	ra	ra	PROPN
iajs-3516	8	21	regular	regular	ADJ
iajs-3516	8	22	tests	test	NOUN
iajs-3516	8	23	at	at	ADP
iajs-3516	8	24	baghdad	baghdad	PROPN
iajs-3516	8	25	teaching	teach	VERB
iajs-3516	8	26	hospital	hospital	NOUN
iajs-3516	8	27	in	in	ADP
iajs-3516	8	28	baghdad	baghdad	PROPN
iajs-3516	8	29	province	province	NOUN
iajs-3516	8	30	.	.	PUNCT
iajs-3516	9	1	the	the	DET
iajs-3516	9	2	apparently	apparently	ADV
iajs-3516	9	3	healthy	healthy	ADJ
iajs-3516	9	4	individuals	individual	NOUN
iajs-3516	9	5	were	be	AUX
iajs-3516	9	6	obtained	obtain	VERB
iajs-3516	9	7	(	(	PUNCT
iajs-3516	9	8	from	from	ADP
iajs-3516	9	9	family	family	NOUN
iajs-3516	9	10	,	,	PUNCT
iajs-3516	9	11	friends	friend	NOUN
iajs-3516	9	12	,	,	PUNCT
iajs-3516	9	13	and	and	CCONJ
iajs-3516	9	14	other	other	ADJ
iajs-3516	9	15	acquaintances	acquaintance	NOUN
iajs-3516	9	16	after	after	ADP
iajs-3516	9	17	routine	routine	ADJ
iajs-3516	9	18	examinations	examination	NOUN
iajs-3516	9	19	)	)	PUNCT
iajs-3516	9	20	with	with	ADP
iajs-3516	9	21	age	age	NOUN
iajs-3516	9	22	and	and	CCONJ
iajs-3516	9	23	sex	sex	NOUN
iajs-3516	9	24	matched	match	VERB
iajs-3516	9	25	with	with	ADP
iajs-3516	9	26	patients	patient	NOUN
iajs-3516	9	27	.	.	PUNCT
iajs-3516	10	1	we	we	PRON
iajs-3516	10	2	immunologically	immunologically	ADV
iajs-3516	10	3	examined	examine	VERB
iajs-3516	10	4	all	all	DET
iajs-3516	10	5	90	90	NUM
iajs-3516	10	6	samples	sample	NOUN
iajs-3516	10	7	to	to	PART
iajs-3516	10	8	detect	detect	VERB
iajs-3516	10	9	epstein	epstein	PROPN
iajs-3516	10	10	-	-	PUNCT
iajs-3516	10	11	barr	barr	PROPN
iajs-3516	10	12	virus	virus	PROPN
iajs-3516	10	13	(	(	PUNCT
iajs-3516	10	14	ebv	ebv	NOUN
iajs-3516	10	15	)	)	PUNCT
iajs-3516	10	16	infection	infection	NOUN
iajs-3516	10	17	using	use	VERB
iajs-3516	10	18	both	both	DET
iajs-3516	10	19	epstein	epstein	PROPN
iajs-3516	10	20	-	-	PUNCT
iajs-3516	10	21	barr	barr	PROPN
iajs-3516	10	22	viral	viral	PROPN
iajs-3516	10	23	capsid	capsid	PROPN
iajs-3516	10	24	ag	ag	PROPN
iajs-3516	10	25	(	(	PUNCT
iajs-3516	10	26	vca	vca	PROPN
iajs-3516	10	27	)	)	PUNCT
iajs-3516	10	28	igg	igg	PROPN
iajs-3516	10	29	and	and	CCONJ
iajs-3516	10	30	epstein	epstein	PROPN
iajs-3516	10	31	barr	barr	PROPN
iajs-3516	10	32	nuclear	nuclear	PROPN
iajs-3516	10	33	ag	ag	PROPN
iajs-3516	10	34	(	(	PUNCT
iajs-3516	10	35	ebna	ebna	NOUN
iajs-3516	10	36	)	)	PUNCT
iajs-3516	10	37	igg	igg	PROPN
iajs-3516	10	38	enzyme	enzyme	NOUN
iajs-3516	10	39	-	-	PUNCT
iajs-3516	10	40	linked	link	VERB
iajs-3516	10	41	immunosorbent	immunosorbent	NOUN
iajs-3516	10	42	assay	assay	PROPN
iajs-3516	10	43	(	(	PUNCT
iajs-3516	10	44	elisa	elisa	NOUN
iajs-3516	10	45	)	)	PUNCT
iajs-3516	10	46	.	.	PUNCT
iajs-3516	11	1	the	the	DET
iajs-3516	11	2	results	result	NOUN
iajs-3516	11	3	showed	show	VERB
iajs-3516	11	4	that	that	SCONJ
iajs-3516	11	5	(	(	PUNCT
iajs-3516	11	6	66.7	66.7	NUM
iajs-3516	11	7	%	%	NOUN
iajs-3516	11	8	)	)	PUNCT
iajs-3516	11	9	of	of	ADP
iajs-3516	11	10	ra	ra	PROPN
iajs-3516	11	11	patients	patient	NOUN
iajs-3516	11	12	and	and	CCONJ
iajs-3516	11	13	(	(	PUNCT
iajs-3516	11	14	60	60	NUM
iajs-3516	11	15	%	%	NOUN
iajs-3516	11	16	)	)	PUNCT
iajs-3516	11	17	of	of	ADP
iajs-3516	11	18	controls	control	NOUN
iajs-3516	11	19	were	be	AUX
iajs-3516	11	20	positive	positive	ADJ
iajs-3516	11	21	for	for	ADP
iajs-3516	11	22	vca	vca	PROPN
iajs-3516	11	23	,	,	PUNCT
iajs-3516	11	24	while	while	SCONJ
iajs-3516	11	25	(	(	PUNCT
iajs-3516	11	26	57.8	57.8	NUM
iajs-3516	11	27	%	%	NOUN
iajs-3516	11	28	)	)	PUNCT
iajs-3516	11	29	and	and	CCONJ
iajs-3516	11	30	(	(	PUNCT
iajs-3516	11	31	51.1	51.1	NUM
iajs-3516	11	32	%	%	NOUN
iajs-3516	11	33	)	)	PUNCT
iajs-3516	11	34	were	be	AUX
iajs-3516	11	35	positive	positive	ADJ
iajs-3516	11	36	for	for	ADP
iajs-3516	11	37	ebna	ebna	NOUN
iajs-3516	11	38	in	in	ADP
iajs-3516	11	39	patients	patient	NOUN
iajs-3516	11	40	and	and	CCONJ
iajs-3516	11	41	controls	control	NOUN
iajs-3516	11	42	,	,	PUNCT
iajs-3516	11	43	respectively	respectively	ADV
iajs-3516	11	44	.	.	PUNCT
iajs-3516	12	1	according	accord	VERB
iajs-3516	12	2	to	to	ADP
iajs-3516	12	3	disease	disease	NOUN
iajs-3516	12	4	activity	activity	NOUN
iajs-3516	12	5	,	,	PUNCT
iajs-3516	12	6	there	there	PRON
iajs-3516	12	7	were	be	VERB
iajs-3516	12	8	(	(	PUNCT
iajs-3516	12	9	33.33	33.33	NUM
iajs-3516	12	10	%	%	NOUN
iajs-3516	12	11	)	)	PUNCT
iajs-3516	12	12	and	and	CCONJ
iajs-3516	12	13	(	(	PUNCT
iajs-3516	12	14	34.62	34.62	NUM
iajs-3516	12	15	%	%	NOUN
iajs-3516	12	16	)	)	PUNCT
iajs-3516	12	17	at	at	ADP
iajs-3516	12	18	high	high	ADJ
iajs-3516	12	19	disease	disease	NOUN
iajs-3516	12	20	activity	activity	NOUN
iajs-3516	12	21	,	,	PUNCT
iajs-3516	12	22	while	while	SCONJ
iajs-3516	12	23	(	(	PUNCT
iajs-3516	12	24	66.67	66.67	NUM
iajs-3516	12	25	%	%	NOUN
iajs-3516	12	26	)	)	PUNCT
iajs-3516	12	27	and	and	CCONJ
iajs-3516	12	28	(	(	PUNCT
iajs-3516	12	29	65.38	65.38	NUM
iajs-3516	12	30	%	%	NOUN
iajs-3516	12	31	)	)	PUNCT
iajs-3516	12	32	at	at	ADP
iajs-3516	12	33	moderate	moderate	ADJ
iajs-3516	12	34	disease	disease	NOUN
iajs-3516	12	35	activity	activity	NOUN
iajs-3516	12	36	were	be	AUX
iajs-3516	12	37	positive	positive	ADJ
iajs-3516	12	38	for	for	ADP
iajs-3516	12	39	vca	vca	PROPN
iajs-3516	12	40	and	and	CCONJ
iajs-3516	12	41	ebna	ebna	NOUN
iajs-3516	12	42	,	,	PUNCT
iajs-3516	12	43	respectively	respectively	ADV
iajs-3516	12	44	.	.	PUNCT
iajs-3516	13	1	in	in	ADP
iajs-3516	13	2	conclusion	conclusion	NOUN
iajs-3516	13	3	,	,	PUNCT
iajs-3516	13	4	these	these	DET
iajs-3516	13	5	findings	finding	NOUN
iajs-3516	13	6	do	do	AUX
iajs-3516	13	7	not	not	PART
iajs-3516	13	8	reveal	reveal	VERB
iajs-3516	13	9	a	a	DET
iajs-3516	13	10	relationship	relationship	NOUN
iajs-3516	13	11	between	between	ADP
iajs-3516	13	12	ebv	ebv	NOUN
iajs-3516	13	13	seroprevalence	seroprevalence	NOUN
iajs-3516	13	14	and	and	CCONJ
iajs-3516	13	15	ra	ra	NOUN
iajs-3516	13	16	,	,	PUNCT
iajs-3516	13	17	and	and	CCONJ
iajs-3516	13	18	as	as	ADP
iajs-3516	13	19	a	a	DET
iajs-3516	13	20	result	result	NOUN
iajs-3516	13	21	,	,	PUNCT
iajs-3516	13	22	they	they	PRON
iajs-3516	13	23	do	do	AUX
iajs-3516	13	24	not	not	PART
iajs-3516	13	25	support	support	VERB
iajs-3516	13	26	the	the	DET
iajs-3516	13	27	concept	concept	NOUN
iajs-3516	13	28	that	that	SCONJ
iajs-3516	13	29	a	a	DET
iajs-3516	13	30	previous	previous	ADJ
iajs-3516	13	31	infection	infection	NOUN
iajs-3516	13	32	with	with	ADP
iajs-3516	13	33	ebv	ebv	NOUN
iajs-3516	13	34	predisposes	predispose	NOUN
iajs-3516	13	35	individuals	individual	NOUN
iajs-3516	13	36	to	to	ADP
iajs-3516	13	37	the	the	DET
iajs-3516	13	38	development	development	NOUN
iajs-3516	13	39	of	of	ADP
iajs-3516	13	40	ra	ra	PROPN
iajs-3516	13	41	.	.	PUNCT
iajs-3516	14	1	keywords	keyword	NOUN
iajs-3516	14	2	:	:	PUNCT
iajs-3516	14	3	epstein	epstein	PROPN
iajs-3516	14	4	-	-	PUNCT
iajs-3516	14	5	barr	barr	PROPN
iajs-3516	14	6	virus	virus	PROPN
iajs-3516	14	7	,	,	PUNCT
iajs-3516	14	8	viral	viral	ADJ
iajs-3516	14	9	capsid	capsid	PROPN
iajs-3516	14	10	ag	ag	PROPN
iajs-3516	14	11	,	,	PUNCT
iajs-3516	14	12	epstein	epstein	PROPN
iajs-3516	14	13	barr	barr	PROPN
iajs-3516	14	14	nuclear	nuclear	PROPN
iajs-3516	14	15	ag	ag	PROPN
iajs-3516	14	16	,	,	PUNCT
iajs-3516	14	17	rheumatoid	rheumatoid	VERB
iajs-3516	14	18	arthritis	arthritis	NOUN
iajs-3516	14	19	.	.	PUNCT
iajs-3516	15	1	1	1	X
iajs-3516	15	2	.	.	X
iajs-3516	15	3	introduction	introduction	NOUN
iajs-3516	15	4	rheumatoid	rheumatoid	NOUN
iajs-3516	15	5	arthritis	arthritis	NOUN
iajs-3516	15	6	(	(	PUNCT
iajs-3516	15	7	ra	ra	NOUN
iajs-3516	15	8	)	)	PUNCT
iajs-3516	15	9	is	be	AUX
iajs-3516	15	10	a	a	DET
iajs-3516	15	11	persistent	persistent	ADJ
iajs-3516	15	12	inflammatory	inflammatory	ADJ
iajs-3516	15	13	disease	disease	NOUN
iajs-3516	15	14	that	that	PRON
iajs-3516	15	15	predominantly	predominantly	ADV
iajs-3516	15	16	impacts	impact	VERB
iajs-3516	15	17	the	the	DET
iajs-3516	15	18	synovial	synovial	ADJ
iajs-3516	15	19	membrane	membrane	NOUN
iajs-3516	15	20	lining	lining	NOUN
iajs-3516	15	21	of	of	ADP
iajs-3516	15	22	the	the	DET
iajs-3516	15	23	joints	joint	NOUN
iajs-3516	15	24	that	that	PRON
iajs-3516	15	25	ultimately	ultimately	ADV
iajs-3516	15	26	leads	lead	VERB
iajs-3516	15	27	to	to	ADP
iajs-3516	15	28	joint	joint	ADJ
iajs-3516	15	29	destruction	destruction	NOUN
iajs-3516	15	30	(	(	PUNCT
iajs-3516	15	31	1	1	NUM
iajs-3516	15	32	)	)	PUNCT
iajs-3516	15	33	.	.	PUNCT
iajs-3516	16	1	there	there	PRON
iajs-3516	16	2	is	be	VERB
iajs-3516	16	3	a	a	DET
iajs-3516	16	4	correlation	correlation	NOUN
iajs-3516	16	5	between	between	ADP
iajs-3516	16	6	rheumatoid	rheumatoid	NOUN
iajs-3516	16	7	arthritis	arthritis	NOUN
iajs-3516	16	8	and	and	CCONJ
iajs-3516	16	9	worsening	worsen	VERB
iajs-3516	16	10	disability	disability	NOUN
iajs-3516	16	11	,	,	PUNCT
iajs-3516	16	12	as	as	ADV
iajs-3516	16	13	well	well	ADV
iajs-3516	16	14	as	as	ADP
iajs-3516	16	15	premature	premature	ADJ
iajs-3516	16	16	mortality	mortality	NOUN
iajs-3516	16	17	and	and	CCONJ
iajs-3516	16	18	socioeconomic	socioeconomic	ADJ
iajs-3516	16	19	problems	problem	NOUN
iajs-3516	16	20	(	(	PUNCT
iajs-3516	16	21	2	2	NUM
iajs-3516	16	22	)	)	PUNCT
iajs-3516	16	23	.	.	PUNCT
iajs-3516	17	1	in	in	ADP
iajs-3516	17	2	rheumatoid	rheumatoid	NOUN
iajs-3516	17	3	arthritis	arthritis	NOUN
iajs-3516	17	4	,	,	PUNCT
iajs-3516	17	5	your	your	PRON
iajs-3516	17	6	immune	immune	ADJ
iajs-3516	17	7	system	system	NOUN
iajs-3516	17	8	attacks	attack	VERB
iajs-3516	17	9	the	the	DET
iajs-3516	17	10	tissue	tissue	NOUN
iajs-3516	17	11	lining	line	VERB
iajs-3516	17	12	the	the	DET
iajs-3516	17	13	joints	joint	NOUN
iajs-3516	17	14	on	on	ADP
iajs-3516	17	15	both	both	DET
iajs-3516	17	16	sides	side	NOUN
iajs-3516	17	17	of	of	ADP
iajs-3516	17	18	your	your	PRON
iajs-3516	17	19	body	body	NOUN
iajs-3516	17	20	;	;	PUNCT
iajs-3516	17	21	other	other	ADJ
iajs-3516	17	22	parts	part	NOUN
iajs-3516	17	23	of	of	ADP
iajs-3516	17	24	the	the	DET
iajs-3516	17	25	body	body	NOUN
iajs-3516	17	26	may	may	AUX
iajs-3516	17	27	also	also	ADV
iajs-3516	17	28	be	be	AUX
iajs-3516	17	29	affected	affect	VERB
iajs-3516	17	30	(	(	PUNCT
iajs-3516	17	31	3	3	NUM
iajs-3516	17	32	)	)	PUNCT
iajs-3516	17	33	.	.	PUNCT
iajs-3516	18	1	the	the	DET
iajs-3516	18	2	cause	cause	NOUN
iajs-3516	18	3	is	be	AUX
iajs-3516	18	4	unknown	unknown	ADJ
iajs-3516	18	5	,	,	PUNCT
iajs-3516	18	6	but	but	CCONJ
iajs-3516	18	7	in	in	ADP
iajs-3516	18	8	up	up	ADP
iajs-3516	18	9	to	to	PART
iajs-3516	18	10	20	20	NUM
iajs-3516	18	11	%	%	NOUN
iajs-3516	18	12	of	of	ADP
iajs-3516	18	13	cases	case	NOUN
iajs-3516	18	14	,	,	PUNCT
iajs-3516	18	15	infections	infection	NOUN
iajs-3516	18	16	have	have	AUX
iajs-3516	18	17	been	be	AUX
iajs-3516	18	18	thought	think	VERB
iajs-3516	18	19	to	to	PART
iajs-3516	18	20	be	be	AUX
iajs-3516	18	21	environmental	environmental	ADJ
iajs-3516	18	22	https://orcid.org/0000-0003-1066-1091	https://orcid.org/0000-0003-1066-1091	PROPN
iajs-3516	18	23	mailto:wafaa.ayad@mu.edu.iq	mailto:wafaa.ayad@mu.edu.iq	PROPN
iajs-3516	18	24	https://orcid.org/0000-0003-0379-1584	https://orcid.org/0000-0003-0379-1584	PROPN
iajs-3516	18	25	mailto:dunyascience@sc.uobaghdad.edu.iq	mailto:dunyascience@sc.uobaghdad.edu.iq	PROPN
iajs-3516	18	26	https://orcid.org/0000-0003-1066-1091	https://orcid.org/0000-0003-1066-1091	PROPN
iajs-3516	18	27	mailto:wafaa.ayad@mu.edu.iq	mailto:wafaa.ayad@mu.edu.iq	PROPN
iajs-3516	18	28	https://orcid.org/0000-0003-0379-1584	https://orcid.org/0000-0003-0379-1584	PROPN
iajs-3516	18	29	mailto:dunyascience@sc.uobaghdad.edu.iq	mailto:dunyascience@sc.uobaghdad.edu.iq	PROPN
iajs-3516	18	30	https://orcid.org/0000-0003-1066-1091	https://orcid.org/0000-0003-1066-1091	PROPN
iajs-3516	18	31	mailto:wafaa.ayad@mu.edu.iq	mailto:wafaa.ayad@mu.edu.iq	PROPN
iajs-3516	18	32	https://orcid.org/0000-0003-0379-1584	https://orcid.org/0000-0003-0379-1584	PROPN
iajs-3516	18	33	mailto:dunyascience@sc.uobaghdad.edu.iq	mailto:dunyascience@sc.uobaghdad.edu.iq	PROPN
iajs-3516	18	34	https://orcid.org/0000-0003-1066-1091	https://orcid.org/0000-0003-1066-1091	PROPN
iajs-3516	18	35	mailto:wafaa.ayad@mu.edu.iq	mailto:wafaa.ayad@mu.edu.iq	PROPN
iajs-3516	18	36	https://orcid.org/0000-0003-0379-1584	https://orcid.org/0000-0003-0379-1584	PROPN
iajs-3516	18	37	mailto:dunyascience@sc.uobaghdad.edu.iq	mailto:dunyascience@sc.uobaghdad.edu.iq	PROPN
iajs-3516	18	38	https://orcid.org/0000-0003-1066-1091	https://orcid.org/0000-0003-1066-1091	PROPN
iajs-3516	18	39	mailto:wafaa.ayad@mu.edu.iq	mailto:wafaa.ayad@mu.edu.iq	PROPN
iajs-3516	18	40	https://orcid.org/0000-0003-0379-1584	https://orcid.org/0000-0003-0379-1584	PROPN
iajs-3516	18	41	mailto:dunyascience@sc.uobaghdad.edu.iq	mailto:dunyascience@sc.uobaghdad.edu.iq	PROPN
iajs-3516	18	42	https://orcid.org/0000-0003-1066-1091	https://orcid.org/0000-0003-1066-1091	PROPN
iajs-3516	18	43	mailto:wafaa.ayad@mu.edu.iq	mailto:wafaa.ayad@mu.edu.iq	PROPN
iajs-3516	18	44	https://orcid.org/0000-0003-0379-1584	https://orcid.org/0000-0003-0379-1584	PROPN
iajs-3516	18	45	mailto:dunyascience@sc.uobaghdad.edu.iq	mailto:dunyascience@sc.uobaghdad.edu.iq	PROPN
iajs-3516	18	46	ihjpas	ihjpas	PROPN
iajs-3516	18	47	.	.	PUNCT
iajs-3516	19	1	2025	2025	NUM
iajs-3516	19	2	,	,	PUNCT
iajs-3516	19	3	38(3	38(3	NUM
iajs-3516	19	4	)	)	PUNCT
iajs-3516	19	5	2	2	NUM
iajs-3516	19	6	triggers	trigger	NOUN
iajs-3516	19	7	.	.	PUNCT
iajs-3516	20	1	researchers	researcher	NOUN
iajs-3516	20	2	are	be	AUX
iajs-3516	20	3	especially	especially	ADV
iajs-3516	20	4	interested	interested	ADJ
iajs-3516	20	5	in	in	ADP
iajs-3516	20	6	viral	viral	ADJ
iajs-3516	20	7	causes	cause	NOUN
iajs-3516	20	8	;	;	PUNCT
iajs-3516	20	9	viral	viral	ADJ
iajs-3516	20	10	infection	infection	NOUN
iajs-3516	20	11	and	and	CCONJ
iajs-3516	20	12	immunity	immunity	NOUN
iajs-3516	20	13	had	have	AUX
iajs-3516	20	14	been	be	AUX
iajs-3516	20	15	suggested	suggest	VERB
iajs-3516	20	16	to	to	PART
iajs-3516	20	17	play	play	VERB
iajs-3516	20	18	a	a	DET
iajs-3516	20	19	role	role	NOUN
iajs-3516	20	20	in	in	ADP
iajs-3516	20	21	the	the	DET
iajs-3516	20	22	pathogenesis	pathogenesis	NOUN
iajs-3516	20	23	of	of	ADP
iajs-3516	20	24	autoimmune	autoimmune	ADJ
iajs-3516	20	25	diseases	disease	NOUN
iajs-3516	20	26	(	(	PUNCT
iajs-3516	20	27	4,5	4,5	NUM
iajs-3516	20	28	)	)	PUNCT
iajs-3516	20	29	.	.	PUNCT
iajs-3516	21	1	so	so	ADV
iajs-3516	21	2	,	,	PUNCT
iajs-3516	21	3	multiple	multiple	ADJ
iajs-3516	21	4	viral	viral	ADJ
iajs-3516	21	5	diseases	disease	NOUN
iajs-3516	21	6	,	,	PUNCT
iajs-3516	21	7	like	like	ADP
iajs-3516	21	8	rubella	rubella	NOUN
iajs-3516	21	9	,	,	PUNCT
iajs-3516	21	10	parvovirus	parvovirus	NOUN
iajs-3516	21	11	b19	b19	NOUN
iajs-3516	21	12	,	,	PUNCT
iajs-3516	21	13	human	human	PROPN
iajs-3516	21	14	t	t	PROPN
iajs-3516	21	15	-	-	PUNCT
iajs-3516	21	16	lymphotropic	lymphotropic	NOUN
iajs-3516	21	17	virus	virus	NOUN
iajs-3516	21	18	type	type	NOUN
iajs-3516	21	19	1	1	NUM
iajs-3516	21	20	(	(	PUNCT
iajs-3516	21	21	htlv-1	htlv-1	NUM
iajs-3516	21	22	)	)	PUNCT
iajs-3516	21	23	,	,	PUNCT
iajs-3516	21	24	hepatitis	hepatitis	PROPN
iajs-3516	21	25	b	b	PROPN
iajs-3516	21	26	and	and	CCONJ
iajs-3516	21	27	c	c	PROPN
iajs-3516	21	28	viruses	virus	NOUN
iajs-3516	21	29	(	(	PUNCT
iajs-3516	21	30	hbv	hbv	NOUN
iajs-3516	21	31	and	and	CCONJ
iajs-3516	21	32	hcv	hcv	NOUN
iajs-3516	21	33	)	)	PUNCT
iajs-3516	21	34	,	,	PUNCT
iajs-3516	21	35	can	can	AUX
iajs-3516	21	36	cause	cause	VERB
iajs-3516	21	37	polyarthritis	polyarthritis	NOUN
iajs-3516	21	38	that	that	PRON
iajs-3516	21	39	looks	look	VERB
iajs-3516	21	40	like	like	ADP
iajs-3516	21	41	(	(	PUNCT
iajs-3516	21	42	6	6	NUM
iajs-3516	21	43	)	)	PUNCT
iajs-3516	21	44	;	;	PUNCT
iajs-3516	21	45	cmv	cmv	NOUN
iajs-3516	21	46	might	might	AUX
iajs-3516	21	47	be	be	AUX
iajs-3516	21	48	one	one	NUM
iajs-3516	21	49	of	of	ADP
iajs-3516	21	50	the	the	DET
iajs-3516	21	51	triggering	trigger	VERB
iajs-3516	21	52	factors	factor	NOUN
iajs-3516	21	53	for	for	ADP
iajs-3516	21	54	ra	ra	PROPN
iajs-3516	21	55	(	(	PUNCT
iajs-3516	21	56	7	7	NUM
iajs-3516	21	57	)	)	PUNCT
iajs-3516	21	58	.	.	PUNCT
iajs-3516	22	1	the	the	DET
iajs-3516	22	2	epstein	epstein	PROPN
iajs-3516	22	3	-	-	PUNCT
iajs-3516	22	4	barr	barr	PROPN
iajs-3516	22	5	virus	virus	PROPN
iajs-3516	22	6	(	(	PUNCT
iajs-3516	22	7	ebv	ebv	NOUN
iajs-3516	22	8	)	)	PUNCT
iajs-3516	22	9	has	have	AUX
iajs-3516	22	10	been	be	AUX
iajs-3516	22	11	suspected	suspect	VERB
iajs-3516	22	12	as	as	ADP
iajs-3516	22	13	a	a	DET
iajs-3516	22	14	contributor	contributor	NOUN
iajs-3516	22	15	to	to	PART
iajs-3516	22	16	rheumatoid	rheumatoid	VERB
iajs-3516	22	17	arthritis	arthritis	NOUN
iajs-3516	22	18	(	(	PUNCT
iajs-3516	22	19	ra	ra	NOUN
iajs-3516	22	20	)	)	PUNCT
iajs-3516	22	21	.	.	PUNCT
iajs-3516	23	1	this	this	PRON
iajs-3516	23	2	is	be	AUX
iajs-3516	23	3	due	due	ADJ
iajs-3516	23	4	to	to	ADP
iajs-3516	23	5	the	the	DET
iajs-3516	23	6	fact	fact	NOUN
iajs-3516	23	7	that	that	SCONJ
iajs-3516	23	8	epstein	epstein	PROPN
iajs-3516	23	9	-	-	PUNCT
iajs-3516	23	10	barr	barr	PROPN
iajs-3516	23	11	virus	virus	PROPN
iajs-3516	23	12	(	(	PUNCT
iajs-3516	23	13	ebv	ebv	NOUN
iajs-3516	23	14	)	)	PUNCT
iajs-3516	23	15	has	have	AUX
iajs-3516	23	16	been	be	AUX
iajs-3516	23	17	related	relate	VERB
iajs-3516	23	18	to	to	ADP
iajs-3516	23	19	several	several	ADJ
iajs-3516	23	20	other	other	ADJ
iajs-3516	23	21	autoimmune	autoimmune	ADJ
iajs-3516	23	22	illnesses	illness	NOUN
iajs-3516	23	23	,	,	PUNCT
iajs-3516	23	24	including	include	VERB
iajs-3516	23	25	multiple	multiple	ADJ
iajs-3516	23	26	sclerosis	sclerosis	NOUN
iajs-3516	23	27	(	(	PUNCT
iajs-3516	23	28	ms	ms	NOUN
iajs-3516	23	29	)	)	PUNCT
iajs-3516	23	30	and	and	CCONJ
iajs-3516	23	31	lupus	lupus	NOUN
iajs-3516	23	32	,	,	PUNCT
iajs-3516	23	33	while	while	SCONJ
iajs-3516	23	34	there	there	PRON
iajs-3516	23	35	was	be	VERB
iajs-3516	23	36	a	a	DET
iajs-3516	23	37	non	non	ADJ
iajs-3516	23	38	-	-	ADJ
iajs-3516	23	39	significant	significant	ADJ
iajs-3516	23	40	association	association	NOUN
iajs-3516	23	41	between	between	ADP
iajs-3516	23	42	ebv	ebv	NOUN
iajs-3516	23	43	infection	infection	NOUN
iajs-3516	23	44	and	and	CCONJ
iajs-3516	23	45	reactive	reactive	ADJ
iajs-3516	23	46	arthritis	arthritis	NOUN
iajs-3516	23	47	(	(	PUNCT
iajs-3516	23	48	rea	rea	NOUN
iajs-3516	23	49	)	)	PUNCT
iajs-3516	23	50	disease	disease	NOUN
iajs-3516	23	51	development	development	NOUN
iajs-3516	23	52	(	(	PUNCT
iajs-3516	23	53	8)	8)	NUM
iajs-3516	23	54	.	.	PUNCT
iajs-3516	24	1	ebv	ebv	NOUN
iajs-3516	24	2	is	be	AUX
iajs-3516	24	3	a	a	DET
iajs-3516	24	4	dna	dna	PROPN
iajs-3516	24	5	virus	virus	NOUN
iajs-3516	24	6	belonging	belong	VERB
iajs-3516	24	7	to	to	ADP
iajs-3516	24	8	the	the	DET
iajs-3516	24	9	gamma	gamma	PROPN
iajs-3516	24	10	herpesviruses	herpesviruse	NOUN
iajs-3516	24	11	subfamily	subfamily	ADV
iajs-3516	24	12	of	of	ADP
iajs-3516	24	13	the	the	DET
iajs-3516	24	14	herpesviridae	herpesviridae	NOUN
iajs-3516	24	15	family	family	NOUN
iajs-3516	24	16	that	that	PRON
iajs-3516	24	17	infects	infect	VERB
iajs-3516	24	18	more	more	ADJ
iajs-3516	24	19	than	than	ADP
iajs-3516	24	20	98	98	NUM
iajs-3516	24	21	percent	percent	NOUN
iajs-3516	24	22	of	of	ADP
iajs-3516	24	23	the	the	DET
iajs-3516	24	24	global	global	ADJ
iajs-3516	24	25	population	population	NOUN
iajs-3516	24	26	by	by	ADP
iajs-3516	24	27	the	the	DET
iajs-3516	24	28	age	age	NOUN
iajs-3516	24	29	of	of	ADP
iajs-3516	24	30	forty	forty	NUM
iajs-3516	24	31	.	.	PUNCT
iajs-3516	25	1	it	it	PRON
iajs-3516	25	2	is	be	AUX
iajs-3516	25	3	the	the	DET
iajs-3516	25	4	infectious	infectious	ADJ
iajs-3516	25	5	agent	agent	NOUN
iajs-3516	25	6	that	that	PRON
iajs-3516	25	7	causes	cause	VERB
iajs-3516	25	8	infectious	infectious	ADJ
iajs-3516	25	9	mononucleosis	mononucleosis	NOUN
iajs-3516	25	10	(	(	PUNCT
iajs-3516	25	11	i	i	NOUN
iajs-3516	25	12	m	m	PROPN
iajs-3516	25	13	)	)	PUNCT
iajs-3516	25	14	,	,	PUNCT
iajs-3516	25	15	which	which	PRON
iajs-3516	25	16	is	be	AUX
iajs-3516	25	17	a	a	DET
iajs-3516	25	18	contagious	contagious	ADJ
iajs-3516	25	19	disease	disease	NOUN
iajs-3516	25	20	.	.	PUNCT
iajs-3516	26	1	it	it	PRON
iajs-3516	26	2	is	be	AUX
iajs-3516	26	3	highly	highly	ADV
iajs-3516	26	4	associated	associate	VERB
iajs-3516	26	5	with	with	ADP
iajs-3516	26	6	a	a	DET
iajs-3516	26	7	number	number	NOUN
iajs-3516	26	8	of	of	ADP
iajs-3516	26	9	cancers	cancer	NOUN
iajs-3516	26	10	,	,	PUNCT
iajs-3516	26	11	such	such	ADJ
iajs-3516	26	12	as	as	ADP
iajs-3516	26	13	lymphoproliferative	lymphoproliferative	ADJ
iajs-3516	26	14	diseases	disease	NOUN
iajs-3516	26	15	in	in	ADP
iajs-3516	26	16	those	those	PRON
iajs-3516	26	17	with	with	ADP
iajs-3516	26	18	immunodeficiency	immunodeficiency	NOUN
iajs-3516	26	19	,	,	PUNCT
iajs-3516	26	20	including	include	VERB
iajs-3516	26	21	hodgkin	hodgkin	PROPN
iajs-3516	26	22	's	's	PART
iajs-3516	26	23	disease	disease	NOUN
iajs-3516	26	24	,	,	PUNCT
iajs-3516	26	25	burkitt	burkitt	PROPN
iajs-3516	26	26	's	's	PART
iajs-3516	26	27	lymphoma	lymphoma	NOUN
iajs-3516	26	28	,	,	PUNCT
iajs-3516	26	29	t	t	PROPN
iajs-3516	26	30	/	/	SYM
iajs-3516	26	31	nk	nk	PROPN
iajs-3516	26	32	cell	cell	NOUN
iajs-3516	26	33	lymphomas	lymphoma	NOUN
iajs-3516	26	34	,	,	PUNCT
iajs-3516	26	35	and	and	CCONJ
iajs-3516	26	36	nasopharyngeal	nasopharyngeal	ADJ
iajs-3516	26	37	carcinoma	carcinoma	NOUN
iajs-3516	26	38	.	.	PUNCT
iajs-3516	27	1	also	also	ADV
iajs-3516	27	2	,	,	PUNCT
iajs-3516	27	3	ebv	ebv	NOUN
iajs-3516	27	4	induces	induce	VERB
iajs-3516	27	5	polyclonal	polyclonal	ADJ
iajs-3516	27	6	lymphocyte	lymphocyte	ADJ
iajs-3516	27	7	proliferation	proliferation	NOUN
iajs-3516	27	8	and	and	CCONJ
iajs-3516	27	9	resides	reside	VERB
iajs-3516	27	10	in	in	ADP
iajs-3516	27	11	b	b	NOUN
iajs-3516	27	12	lymphocytes	lymphocyte	NOUN
iajs-3516	27	13	for	for	ADP
iajs-3516	27	14	the	the	DET
iajs-3516	27	15	life	life	NOUN
iajs-3516	27	16	of	of	ADP
iajs-3516	27	17	the	the	DET
iajs-3516	27	18	host	host	NOUN
iajs-3516	27	19	,	,	PUNCT
iajs-3516	27	20	despite	despite	SCONJ
iajs-3516	27	21	the	the	DET
iajs-3516	27	22	immune	immune	ADJ
iajs-3516	27	23	response	response	NOUN
iajs-3516	27	24	preventing	prevent	VERB
iajs-3516	27	25	it	it	PRON
iajs-3516	27	26	from	from	ADP
iajs-3516	27	27	reactivating	reactivate	VERB
iajs-3516	27	28	.	.	PUNCT
iajs-3516	28	1	according	accord	VERB
iajs-3516	28	2	to	to	ADP
iajs-3516	28	3	(	(	PUNCT
iajs-3516	28	4	6	6	NUM
iajs-3516	28	5	)	)	PUNCT
iajs-3516	28	6	,	,	PUNCT
iajs-3516	28	7	it	it	PRON
iajs-3516	28	8	is	be	AUX
iajs-3516	28	9	possible	possible	ADJ
iajs-3516	28	10	that	that	SCONJ
iajs-3516	28	11	the	the	DET
iajs-3516	28	12	immunomodulating	immunomodulating	ADJ
iajs-3516	28	13	effects	effect	NOUN
iajs-3516	28	14	that	that	PRON
iajs-3516	28	15	it	it	PRON
iajs-3516	28	16	possesses	possess	VERB
iajs-3516	28	17	in	in	ADP
iajs-3516	28	18	its	its	PRON
iajs-3516	28	19	dormant	dormant	NOUN
iajs-3516	28	20	and	and	CCONJ
iajs-3516	28	21	replicating	replicate	VERB
iajs-3516	28	22	forms	form	NOUN
iajs-3516	28	23	could	could	AUX
iajs-3516	28	24	contribute	contribute	VERB
iajs-3516	28	25	to	to	ADP
iajs-3516	28	26	the	the	DET
iajs-3516	28	27	progression	progression	NOUN
iajs-3516	28	28	of	of	ADP
iajs-3516	28	29	this	this	DET
iajs-3516	28	30	autoimmune	autoimmune	ADJ
iajs-3516	28	31	disease	disease	NOUN
iajs-3516	28	32	over	over	ADP
iajs-3516	28	33	time	time	NOUN
iajs-3516	28	34	(	(	PUNCT
iajs-3516	28	35	6	6	NUM
iajs-3516	28	36	)	)	PUNCT
iajs-3516	28	37	.	.	PUNCT
iajs-3516	29	1	antibodies	antibodie	VERB
iajs-3516	29	2	against	against	ADP
iajs-3516	29	3	ebv	ebv	NOUN
iajs-3516	29	4	antigens	antigen	NOUN
iajs-3516	29	5	are	be	AUX
iajs-3516	29	6	commonly	commonly	ADV
iajs-3516	29	7	detected	detect	VERB
iajs-3516	29	8	in	in	ADP
iajs-3516	29	9	a	a	DET
iajs-3516	29	10	laboratory	laboratory	NOUN
iajs-3516	29	11	setting	setting	NOUN
iajs-3516	29	12	for	for	ADP
iajs-3516	29	13	the	the	DET
iajs-3516	29	14	purpose	purpose	NOUN
iajs-3516	29	15	of	of	ADP
iajs-3516	29	16	identifying	identify	VERB
iajs-3516	29	17	ebv	ebv	NOUN
iajs-3516	29	18	infection	infection	NOUN
iajs-3516	29	19	.	.	PUNCT
iajs-3516	30	1	antigens	antigen	NOUN
iajs-3516	30	2	like	like	ADP
iajs-3516	30	3	early	early	ADJ
iajs-3516	30	4	antigen	antigen	ADJ
iajs-3516	30	5	complex	complex	ADJ
iajs-3516	30	6	diffuse	diffuse	NOUN
iajs-3516	30	7	(	(	PUNCT
iajs-3516	30	8	ea	ea	NOUN
iajs-3516	30	9	-	-	NOUN
iajs-3516	30	10	d	d	NOUN
iajs-3516	30	11	)	)	PUNCT
iajs-3516	30	12	,	,	PUNCT
iajs-3516	30	13	early	early	ADJ
iajs-3516	30	14	antigen	antigen	ADJ
iajs-3516	30	15	complex	complex	ADJ
iajs-3516	30	16	restricted	restrict	VERB
iajs-3516	30	17	(	(	PUNCT
iajs-3516	30	18	ea	ea	NOUN
iajs-3516	30	19	-	-	PUNCT
iajs-3516	30	20	r	r	NOUN
iajs-3516	30	21	)	)	PUNCT
iajs-3516	30	22	,	,	PUNCT
iajs-3516	30	23	epstein	epstein	PROPN
iajs-3516	30	24	-	-	PUNCT
iajs-3516	30	25	barr	barr	PROPN
iajs-3516	30	26	virus	virus	PROPN
iajs-3516	30	27	nuclear	nuclear	ADJ
iajs-3516	30	28	antigen	antigen	NOUN
iajs-3516	30	29	(	(	PUNCT
iajs-3516	30	30	ebna	ebna	NOUN
iajs-3516	30	31	)	)	PUNCT
iajs-3516	30	32	-1	-1	NOUN
iajs-3516	30	33	,	,	PUNCT
iajs-3516	30	34	and	and	CCONJ
iajs-3516	30	35	viral	viral	ADJ
iajs-3516	30	36	capsid	capsid	ADJ
iajs-3516	30	37	antigen	antigen	NOUN
iajs-3516	30	38	(	(	PUNCT
iajs-3516	30	39	vca	vca	PROPN
iajs-3516	30	40	)	)	PUNCT
iajs-3516	30	41	and	and	CCONJ
iajs-3516	30	42	.	.	PUNCT
iajs-3516	31	1	a	a	DET
iajs-3516	31	2	patient	patient	NOUN
iajs-3516	31	3	's	's	PART
iajs-3516	31	4	stage	stage	NOUN
iajs-3516	31	5	of	of	ADP
iajs-3516	31	6	ebv	ebv	NOUN
iajs-3516	31	7	infection	infection	NOUN
iajs-3516	31	8	can	can	AUX
iajs-3516	31	9	be	be	AUX
iajs-3516	31	10	identified	identify	VERB
iajs-3516	31	11	using	use	VERB
iajs-3516	31	12	antibodies	antibody	NOUN
iajs-3516	31	13	against	against	ADP
iajs-3516	31	14	these	these	DET
iajs-3516	31	15	antigens	antigen	NOUN
iajs-3516	31	16	.	.	PUNCT
iajs-3516	32	1	antibodies	antibodie	VERB
iajs-3516	32	2	to	to	ADP
iajs-3516	32	3	ea	ea	SYM
iajs-3516	32	4	,	,	PUNCT
iajs-3516	32	5	on	on	ADP
iajs-3516	32	6	the	the	DET
iajs-3516	32	7	other	other	ADJ
iajs-3516	32	8	hand	hand	NOUN
iajs-3516	32	9	,	,	PUNCT
iajs-3516	32	10	are	be	AUX
iajs-3516	32	11	believed	believe	VERB
iajs-3516	32	12	to	to	PART
iajs-3516	32	13	point	point	VERB
iajs-3516	32	14	to	to	ADP
iajs-3516	32	15	ongoing	ongoing	ADJ
iajs-3516	32	16	replication	replication	NOUN
iajs-3516	32	17	of	of	ADP
iajs-3516	32	18	ebv	ebv	NOUN
iajs-3516	32	19	,	,	PUNCT
iajs-3516	32	20	whilst	whilst	SCONJ
iajs-3516	32	21	antibodies	antibody	NOUN
iajs-3516	32	22	against	against	ADP
iajs-3516	32	23	vca	vca	PROPN
iajs-3516	32	24	and	and	CCONJ
iajs-3516	32	25	ebna-1	ebna-1	NUM
iajs-3516	32	26	are	be	AUX
iajs-3516	32	27	expected	expect	VERB
iajs-3516	32	28	to	to	PART
iajs-3516	32	29	remain	remain	VERB
iajs-3516	32	30	in	in	ADP
iajs-3516	32	31	the	the	DET
iajs-3516	32	32	host	host	NOUN
iajs-3516	32	33	during	during	ADP
iajs-3516	32	34	their	their	PRON
iajs-3516	32	35	whole	whole	ADJ
iajs-3516	32	36	lifetime	lifetime	NOUN
iajs-3516	32	37	(	(	PUNCT
iajs-3516	32	38	9	9	NUM
iajs-3516	32	39	)	)	PUNCT
iajs-3516	32	40	.	.	PUNCT
iajs-3516	33	1	this	this	DET
iajs-3516	33	2	study	study	NOUN
iajs-3516	33	3	intends	intend	VERB
iajs-3516	33	4	to	to	PART
iajs-3516	33	5	determine	determine	VERB
iajs-3516	33	6	whether	whether	SCONJ
iajs-3516	33	7	prior	prior	ADJ
iajs-3516	33	8	infection	infection	NOUN
iajs-3516	33	9	with	with	ADP
iajs-3516	33	10	the	the	DET
iajs-3516	33	11	ebv	ebv	NOUN
iajs-3516	33	12	virus	virus	NOUN
iajs-3516	33	13	occurs	occur	VERB
iajs-3516	33	14	more	more	ADV
iajs-3516	33	15	frequently	frequently	ADV
iajs-3516	33	16	in	in	ADP
iajs-3516	33	17	patients	patient	NOUN
iajs-3516	33	18	with	with	ADP
iajs-3516	33	19	ra	ra	PROPN
iajs-3516	33	20	compared	compare	VERB
iajs-3516	33	21	to	to	ADP
iajs-3516	33	22	controls	control	NOUN
iajs-3516	33	23	.	.	PUNCT
iajs-3516	34	1	2	2	X
iajs-3516	34	2	.	.	X
iajs-3516	34	3	materials	material	NOUN
iajs-3516	34	4	and	and	CCONJ
iajs-3516	34	5	methods	method	NOUN
iajs-3516	34	6	in	in	ADP
iajs-3516	34	7	total	total	ADJ
iajs-3516	34	8	,	,	PUNCT
iajs-3516	34	9	90	90	NUM
iajs-3516	34	10	samples	sample	NOUN
iajs-3516	34	11	were	be	AUX
iajs-3516	34	12	taken	take	VERB
iajs-3516	34	13	between	between	ADP
iajs-3516	34	14	october	october	PROPN
iajs-3516	34	15	2022	2022	NUM
iajs-3516	34	16	and	and	CCONJ
iajs-3516	34	17	march	march	PROPN
iajs-3516	34	18	2023	2023	NUM
iajs-3516	34	19	.	.	PUNCT
iajs-3516	35	1	this	this	DET
iajs-3516	35	2	study	study	NOUN
iajs-3516	35	3	included	include	VERB
iajs-3516	35	4	45	45	NUM
iajs-3516	35	5	ra	ra	PROPN
iajs-3516	35	6	patients	patient	NOUN
iajs-3516	35	7	with	with	ADP
iajs-3516	35	8	high	high	ADJ
iajs-3516	35	9	and	and	CCONJ
iajs-3516	35	10	moderate	moderate	ADJ
iajs-3516	35	11	disease	disease	NOUN
iajs-3516	35	12	activity	activity	NOUN
iajs-3516	35	13	,	,	PUNCT
iajs-3516	35	14	while	while	SCONJ
iajs-3516	35	15	the	the	DET
iajs-3516	35	16	ra	ra	PROPN
iajs-3516	35	17	patients	patient	NOUN
iajs-3516	35	18	with	with	ADP
iajs-3516	35	19	low	low	ADJ
iajs-3516	35	20	disease	disease	NOUN
iajs-3516	35	21	activity	activity	NOUN
iajs-3516	35	22	were	be	AUX
iajs-3516	35	23	excluded	exclude	VERB
iajs-3516	35	24	,	,	PUNCT
iajs-3516	35	25	from	from	ADP
iajs-3516	35	26	the	the	DET
iajs-3516	35	27	baghdad	baghdad	PROPN
iajs-3516	35	28	teaching	teaching	NOUN
iajs-3516	35	29	hospital	hospital	NOUN
iajs-3516	35	30	in	in	ADP
iajs-3516	35	31	baghdad	baghdad	PROPN
iajs-3516	35	32	province	province	NOUN
iajs-3516	35	33	,	,	PUNCT
iajs-3516	35	34	who	who	PRON
iajs-3516	35	35	were	be	AUX
iajs-3516	35	36	referred	refer	VERB
iajs-3516	35	37	for	for	ADP
iajs-3516	35	38	standard	standard	ADJ
iajs-3516	35	39	ra	ra	PROPN
iajs-3516	35	40	testing	testing	NOUN
iajs-3516	35	41	by	by	ADP
iajs-3516	35	42	their	their	PRON
iajs-3516	35	43	treating	treat	VERB
iajs-3516	35	44	physician	physician	NOUN
iajs-3516	35	45	(	(	PUNCT
iajs-3516	35	46	10	10	NUM
iajs-3516	35	47	)	)	PUNCT
iajs-3516	35	48	.	.	PUNCT
iajs-3516	36	1	the	the	DET
iajs-3516	36	2	remaining	remain	VERB
iajs-3516	36	3	45	45	NUM
iajs-3516	36	4	were	be	AUX
iajs-3516	36	5	apparently	apparently	ADV
iajs-3516	36	6	healthy	healthy	ADJ
iajs-3516	36	7	individuals	individual	NOUN
iajs-3516	36	8	who	who	PRON
iajs-3516	36	9	were	be	AUX
iajs-3516	36	10	obtained	obtain	VERB
iajs-3516	36	11	from	from	ADP
iajs-3516	36	12	family	family	NOUN
iajs-3516	36	13	,	,	PUNCT
iajs-3516	36	14	friends	friend	NOUN
iajs-3516	36	15	,	,	PUNCT
iajs-3516	36	16	and	and	CCONJ
iajs-3516	36	17	other	other	ADJ
iajs-3516	36	18	acquaintances	acquaintance	NOUN
iajs-3516	36	19	after	after	ADP
iajs-3516	36	20	routine	routine	ADJ
iajs-3516	36	21	examinations	examination	NOUN
iajs-3516	36	22	and	and	CCONJ
iajs-3516	36	23	had	have	VERB
iajs-3516	36	24	age	age	NOUN
iajs-3516	36	25	and	and	CCONJ
iajs-3516	36	26	sex	sex	NOUN
iajs-3516	36	27	matched	match	VERB
iajs-3516	36	28	with	with	ADP
iajs-3516	36	29	the	the	DET
iajs-3516	36	30	patient	patient	NOUN
iajs-3516	36	31	group	group	NOUN
iajs-3516	36	32	.	.	PUNCT
iajs-3516	37	1	after	after	ADP
iajs-3516	37	2	letting	let	VERB
iajs-3516	37	3	3	3	NUM
iajs-3516	37	4	ml	ml	NOUN
iajs-3516	37	5	of	of	ADP
iajs-3516	37	6	blood	blood	NOUN
iajs-3516	37	7	clot	clot	NOUN
iajs-3516	37	8	for	for	ADP
iajs-3516	37	9	30	30	NUM
iajs-3516	37	10	minutes	minute	NOUN
iajs-3516	37	11	at	at	ADP
iajs-3516	37	12	room	room	NOUN
iajs-3516	37	13	temperature	temperature	NOUN
iajs-3516	37	14	(	(	PUNCT
iajs-3516	37	15	25	25	NUM
iajs-3516	37	16	°	°	NOUN
iajs-3516	37	17	c	c	NOUN
iajs-3516	37	18	)	)	PUNCT
iajs-3516	37	19	(	(	PUNCT
iajs-3516	37	20	10	10	NUM
iajs-3516	37	21	)	)	PUNCT
iajs-3516	37	22	,	,	PUNCT
iajs-3516	37	23	it	it	PRON
iajs-3516	37	24	was	be	AUX
iajs-3516	37	25	centrifuged	centrifuge	VERB
iajs-3516	37	26	at	at	ADP
iajs-3516	37	27	3000	3000	NUM
iajs-3516	37	28	rpm	rpm	NOUN
iajs-3516	37	29	/	/	SYM
iajs-3516	37	30	min	min	NOUN
iajs-3516	37	31	for	for	ADP
iajs-3516	37	32	15	15	NUM
iajs-3516	37	33	minutes	minute	NOUN
iajs-3516	37	34	,	,	PUNCT
iajs-3516	37	35	and	and	CCONJ
iajs-3516	37	36	the	the	DET
iajs-3516	37	37	serum	serum	NOUN
iajs-3516	37	38	was	be	AUX
iajs-3516	37	39	separated	separate	VERB
iajs-3516	37	40	out	out	ADP
iajs-3516	37	41	and	and	CCONJ
iajs-3516	37	42	stored	store	VERB
iajs-3516	37	43	at	at	ADP
iajs-3516	37	44	-20	-20	NUM
iajs-3516	37	45	°	°	NOUN
iajs-3516	37	46	c	c	NOUN
iajs-3516	37	47	until	until	SCONJ
iajs-3516	37	48	it	it	PRON
iajs-3516	37	49	was	be	AUX
iajs-3516	37	50	needed	need	VERB
iajs-3516	37	51	for	for	ADP
iajs-3516	37	52	the	the	DET
iajs-3516	37	53	elisa	elisa	NOUN
iajs-3516	37	54	procedure	procedure	NOUN
iajs-3516	37	55	,	,	PUNCT
iajs-3516	37	56	according	accord	VERB
iajs-3516	37	57	to	to	ADP
iajs-3516	37	58	(	(	PUNCT
iajs-3516	37	59	11	11	NUM
iajs-3516	37	60	)	)	PUNCT
iajs-3516	37	61	.	.	PUNCT
iajs-3516	38	1	serological	serological	ADJ
iajs-3516	38	2	detection	detection	NOUN
iajs-3516	38	3	of	of	ADP
iajs-3516	38	4	ebv	ebv	NOUN
iajs-3516	38	5	was	be	AUX
iajs-3516	38	6	applied	apply	VERB
iajs-3516	38	7	using	use	VERB
iajs-3516	38	8	both	both	PRON
iajs-3516	38	9	ebv	ebv	NOUN
iajs-3516	38	10	-	-	PUNCT
iajs-3516	38	11	vca	vca	PROPN
iajs-3516	38	12	igg	igg	PROPN
iajs-3516	38	13	and	and	CCONJ
iajs-3516	38	14	ebna	ebna	PROPN
iajs-3516	38	15	igg	igg	PROPN
iajs-3516	38	16	elisa	elisa	PROPN
iajs-3516	38	17	kits	kits	PROPN
iajs-3516	38	18	(	(	PUNCT
iajs-3516	38	19	monocent	monocent	PROPN
iajs-3516	38	20	/	/	SYM
iajs-3516	38	21	usa	usa	PROPN
iajs-3516	38	22	)	)	PUNCT
iajs-3516	38	23	.	.	PUNCT
iajs-3516	39	1	statistical	statistical	ADJ
iajs-3516	39	2	analysis	analysis	NOUN
iajs-3516	39	3	was	be	AUX
iajs-3516	39	4	done	do	VERB
iajs-3516	39	5	using	use	VERB
iajs-3516	39	6	the	the	DET
iajs-3516	39	7	program	program	NOUN
iajs-3516	39	8	ibm	ibm	PROPN
iajs-3516	39	9	spss	spss	PROPN
iajs-3516	39	10	version	version	NOUN
iajs-3516	39	11	27.0	27.0	NUM
iajs-3516	39	12	,	,	PUNCT
iajs-3516	39	13	and	and	CCONJ
iajs-3516	39	14	the	the	DET
iajs-3516	39	15	test	test	NOUN
iajs-3516	39	16	used	use	VERB
iajs-3516	39	17	for	for	ADP
iajs-3516	39	18	parametric	parametric	ADJ
iajs-3516	39	19	data	datum	NOUN
iajs-3516	39	20	was	be	AUX
iajs-3516	39	21	the	the	DET
iajs-3516	39	22	chi	chi	ADJ
iajs-3516	39	23	-	-	PUNCT
iajs-3516	39	24	square	square	ADJ
iajs-3516	39	25	test	test	NOUN
iajs-3516	39	26	.	.	PUNCT
iajs-3516	40	1	3	3	X
iajs-3516	40	2	.	.	X
iajs-3516	40	3	results	result	VERB
iajs-3516	40	4	the	the	DET
iajs-3516	40	5	results	result	NOUN
iajs-3516	40	6	showed	show	VERB
iajs-3516	40	7	that	that	SCONJ
iajs-3516	40	8	(	(	PUNCT
iajs-3516	40	9	66.7	66.7	NUM
iajs-3516	40	10	%	%	NOUN
iajs-3516	40	11	)	)	PUNCT
iajs-3516	40	12	of	of	ADP
iajs-3516	40	13	ra	ra	PROPN
iajs-3516	40	14	patients	patient	NOUN
iajs-3516	40	15	and	and	CCONJ
iajs-3516	40	16	(	(	PUNCT
iajs-3516	40	17	60	60	NUM
iajs-3516	40	18	%	%	NOUN
iajs-3516	40	19	)	)	PUNCT
iajs-3516	40	20	of	of	ADP
iajs-3516	40	21	controls	control	NOUN
iajs-3516	40	22	were	be	AUX
iajs-3516	40	23	positive	positive	ADJ
iajs-3516	40	24	for	for	ADP
iajs-3516	40	25	vca	vca	PROPN
iajs-3516	40	26	.	.	PUNCT
iajs-3516	41	1	while	while	SCONJ
iajs-3516	41	2	for	for	ADP
iajs-3516	41	3	ebna	ebna	NOUN
iajs-3516	41	4	there	there	PRON
iajs-3516	41	5	were	be	VERB
iajs-3516	41	6	(	(	PUNCT
iajs-3516	41	7	57.8	57.8	NUM
iajs-3516	41	8	%	%	NOUN
iajs-3516	41	9	)	)	PUNCT
iajs-3516	41	10	and	and	CCONJ
iajs-3516	41	11	(	(	PUNCT
iajs-3516	41	12	51.1	51.1	NUM
iajs-3516	41	13	%	%	NOUN
iajs-3516	41	14	)	)	PUNCT
iajs-3516	41	15	positive	positive	ADJ
iajs-3516	41	16	for	for	ADP
iajs-3516	41	17	patients	patient	NOUN
iajs-3516	41	18	and	and	CCONJ
iajs-3516	41	19	controls	control	NOUN
iajs-3516	41	20	,	,	PUNCT
iajs-3516	41	21	respectively	respectively	ADV
iajs-3516	41	22	.	.	PUNCT
iajs-3516	42	1	ihjpas	ihjpas	PROPN
iajs-3516	42	2	.	.	PUNCT
iajs-3516	43	1	2025	2025	NUM
iajs-3516	43	2	,	,	PUNCT
iajs-3516	43	3	38(3	38(3	NUM
iajs-3516	43	4	)	)	PUNCT
iajs-3516	43	5	3	3	NUM
iajs-3516	43	6	the	the	DET
iajs-3516	43	7	tables	table	NOUN
iajs-3516	43	8	(	(	PUNCT
iajs-3516	43	9	1	1	NUM
iajs-3516	43	10	)	)	PUNCT
iajs-3516	43	11	and	and	CCONJ
iajs-3516	43	12	(	(	PUNCT
iajs-3516	43	13	2	2	X
iajs-3516	43	14	)	)	PUNCT
iajs-3516	43	15	showed	show	VERB
iajs-3516	43	16	that	that	SCONJ
iajs-3516	43	17	there	there	PRON
iajs-3516	43	18	were	be	VERB
iajs-3516	43	19	no	no	DET
iajs-3516	43	20	significant	significant	ADJ
iajs-3516	43	21	differences	difference	NOUN
iajs-3516	43	22	between	between	ADP
iajs-3516	43	23	patients	patient	NOUN
iajs-3516	43	24	and	and	CCONJ
iajs-3516	43	25	controls	control	NOUN
iajs-3516	43	26	in	in	ADP
iajs-3516	43	27	infecting	infect	VERB
iajs-3516	43	28	with	with	ADP
iajs-3516	43	29	ebv	ebv	NOUN
iajs-3516	43	30	-	-	PUNCT
iajs-3516	43	31	vca	vca	PROPN
iajs-3516	43	32	and	and	CCONJ
iajs-3516	43	33	ebna	ebna	NOUN
iajs-3516	43	34	.	.	PUNCT
iajs-3516	43	35	table	table	NOUN
iajs-3516	43	36	1	1	NUM
iajs-3516	43	37	.	.	PUNCT
iajs-3516	44	1	the	the	DET
iajs-3516	44	2	percentage	percentage	NOUN
iajs-3516	44	3	of	of	ADP
iajs-3516	44	4	infection	infection	NOUN
iajs-3516	44	5	with	with	ADP
iajs-3516	44	6	ebvviral	ebvviral	ADJ
iajs-3516	44	7	capsid	capsid	ADJ
iajs-3516	44	8	antigen	antigen	NOUN
iajs-3516	44	9	item	item	NOUN
iajs-3516	44	10	positive	positive	ADJ
iajs-3516	44	11	negative	negative	ADJ
iajs-3516	44	12	total	total	ADJ
iajs-3516	44	13	vca	vca	PROPN
iajs-3516	44	14	results	result	NOUN
iajs-3516	44	15	no	no	INTJ
iajs-3516	44	16	.	.	PUNCT
iajs-3516	45	1	(	(	PUNCT
iajs-3516	45	2	%	%	INTJ
iajs-3516	45	3	)	)	PUNCT
iajs-3516	45	4	probability	probability	NOUN
iajs-3516	45	5	patients	patient	NOUN
iajs-3516	45	6	group	group	NOUN
iajs-3516	45	7	control	control	PROPN
iajs-3516	45	8	group	group	PROPN
iajs-3516	45	9	30	30	NUM
iajs-3516	45	10	(	(	PUNCT
iajs-3516	45	11	66.7	66.7	NUM
iajs-3516	45	12	)	)	PUNCT
iajs-3516	45	13	15	15	NUM
iajs-3516	45	14	(	(	PUNCT
iajs-3516	45	15	33.3	33.3	NUM
iajs-3516	45	16	)	)	PUNCT
iajs-3516	45	17	45	45	NUM
iajs-3516	45	18	(	(	PUNCT
iajs-3516	45	19	100.0	100.0	NUM
iajs-3516	45	20	)	)	PUNCT
iajs-3516	45	21	27	27	NUM
iajs-3516	45	22	(	(	PUNCT
iajs-3516	45	23	60.0	60.0	NUM
iajs-3516	45	24	)	)	SYM
iajs-3516	45	25	18	18	NUM
iajs-3516	45	26	(	(	PUNCT
iajs-3516	45	27	40.0	40.0	NUM
iajs-3516	45	28	)	)	PUNCT
iajs-3516	45	29	45	45	NUM
iajs-3516	45	30	(	(	PUNCT
iajs-3516	45	31	100.0	100.0	NUM
iajs-3516	45	32	)	)	PUNCT
iajs-3516	45	33	0.512	0.512	NUM
iajs-3516	45	34	using	use	VERB
iajs-3516	45	35	χ2	χ2	PROPN
iajs-3516	45	36	test	test	NOUN
iajs-3516	45	37	table	table	NOUN
iajs-3516	45	38	2	2	NUM
iajs-3516	45	39	.	.	PUNCT
iajs-3516	46	1	the	the	DET
iajs-3516	46	2	percentage	percentage	NOUN
iajs-3516	46	3	of	of	ADP
iajs-3516	46	4	infection	infection	NOUN
iajs-3516	46	5	with	with	ADP
iajs-3516	46	6	ebvnuclear	ebvnuclear	ADJ
iajs-3516	46	7	antigen	antigen	ADV
iajs-3516	46	8	using	use	VERB
iajs-3516	46	9	χ2	χ2	PROPN
iajs-3516	46	10	test	test	NOUN
iajs-3516	46	11	to	to	PART
iajs-3516	46	12	measure	measure	VERB
iajs-3516	46	13	the	the	DET
iajs-3516	46	14	activity	activity	NOUN
iajs-3516	46	15	of	of	ADP
iajs-3516	46	16	the	the	DET
iajs-3516	46	17	disease	disease	NOUN
iajs-3516	46	18	,	,	PUNCT
iajs-3516	46	19	the	the	DET
iajs-3516	46	20	clinical	clinical	ADJ
iajs-3516	46	21	disease	disease	NOUN
iajs-3516	46	22	assessment	assessment	NOUN
iajs-3516	46	23	index	index	NOUN
iajs-3516	46	24	(	(	PUNCT
iajs-3516	46	25	cdai	cdai	NOUN
iajs-3516	46	26	)	)	PUNCT
iajs-3516	46	27	were	be	AUX
iajs-3516	46	28	used	use	VERB
iajs-3516	46	29	.	.	PUNCT
iajs-3516	47	1	there	there	PRON
iajs-3516	47	2	was	be	VERB
iajs-3516	47	3	significant	significant	ADJ
iajs-3516	47	4	differences	difference	NOUN
iajs-3516	47	5	in	in	ADP
iajs-3516	47	6	tables	table	NOUN
iajs-3516	47	7	(	(	PUNCT
iajs-3516	47	8	3	3	NUM
iajs-3516	47	9	)	)	PUNCT
iajs-3516	47	10	and	and	CCONJ
iajs-3516	47	11	(	(	PUNCT
iajs-3516	47	12	4	4	X
iajs-3516	47	13	)	)	PUNCT
iajs-3516	47	14	in	in	ADP
iajs-3516	47	15	high	high	ADJ
iajs-3516	47	16	and	and	CCONJ
iajs-3516	47	17	moderate	moderate	ADJ
iajs-3516	47	18	ra	ra	PROPN
iajs-3516	47	19	disease	disease	NOUN
iajs-3516	47	20	activity	activity	NOUN
iajs-3516	47	21	infected	infect	VERB
iajs-3516	47	22	with	with	ADP
iajs-3516	47	23	the	the	DET
iajs-3516	47	24	virus	virus	NOUN
iajs-3516	47	25	.	.	PUNCT
iajs-3516	48	1	table	table	NOUN
iajs-3516	48	2	3	3	NUM
iajs-3516	48	3	.	.	PUNCT
iajs-3516	48	4	:	:	PUNCT
iajs-3516	49	1	ra	ra	NOUN
iajs-3516	49	2	disease	disease	NOUN
iajs-3516	49	3	activity	activity	NOUN
iajs-3516	49	4	and	and	CCONJ
iajs-3516	49	5	ebvviral	ebvviral	ADJ
iajs-3516	49	6	capsid	capsid	ADJ
iajs-3516	49	7	antigen	antigen	ADJ
iajs-3516	49	8	disease	disease	NOUN
iajs-3516	49	9	activity	activity	NOUN
iajs-3516	49	10	vca	vca	PROPN
iajs-3516	49	11	results	result	VERB
iajs-3516	49	12	no	no	INTJ
iajs-3516	49	13	.	.	PUNCT
iajs-3516	50	1	(	(	PUNCT
iajs-3516	50	2	%	%	INTJ
iajs-3516	50	3	)	)	PUNCT
iajs-3516	50	4	probability	probability	NOUN
iajs-3516	50	5	high	high	ADJ
iajs-3516	50	6	moderate	moderate	ADJ
iajs-3516	50	7	total	total	NOUN
iajs-3516	50	8	10	10	NUM
iajs-3516	50	9	(	(	PUNCT
iajs-3516	50	10	33.33	33.33	NUM
iajs-3516	50	11	)	)	PUNCT
iajs-3516	50	12	20	20	NUM
iajs-3516	50	13	(	(	PUNCT
iajs-3516	50	14	66.67	66.67	NUM
iajs-3516	50	15	)	)	PUNCT
iajs-3516	50	16	30	30	NUM
iajs-3516	50	17	(	(	PUNCT
iajs-3516	50	18	100.0	100.0	NUM
iajs-3516	50	19	)	)	PUNCT
iajs-3516	50	20	0.010	0.010	NUM
iajs-3516	50	21	*	*	PUNCT
iajs-3516	50	22	χ2	χ2	NOUN
iajs-3516	50	23	test	test	NOUN
iajs-3516	50	24	,	,	PUNCT
iajs-3516	50	25	*	*	PUNCT
iajs-3516	50	26	is	be	AUX
iajs-3516	50	27	significant	significant	ADJ
iajs-3516	50	28	at	at	ADP
iajs-3516	50	29	p	p	NOUN
iajs-3516	50	30	≤	≤	NUM
iajs-3516	50	31	0.05	0.05	NUM
iajs-3516	50	32	.	.	PUNCT
iajs-3516	50	33	table	table	NOUN
iajs-3516	50	34	4	4	NUM
iajs-3516	50	35	.	.	PUNCT
iajs-3516	50	36	ra	ra	NOUN
iajs-3516	50	37	disease	disease	NOUN
iajs-3516	50	38	activity	activity	NOUN
iajs-3516	50	39	and	and	CCONJ
iajs-3516	50	40	ebvnuclear	ebvnuclear	VERB
iajs-3516	50	41	antigen	antigen	ADJ
iajs-3516	50	42	disease	disease	NOUN
iajs-3516	50	43	activity	activity	NOUN
iajs-3516	50	44	ebna	ebna	NOUN
iajs-3516	50	45	results	result	NOUN
iajs-3516	51	1	n.	n.	PROPN
iajs-3516	51	2	(	(	PUNCT
iajs-3516	51	3	%	%	NOUN
iajs-3516	51	4	)	)	PUNCT
iajs-3516	51	5	of	of	ADP
iajs-3516	51	6	patients	patient	NOUN
iajs-3516	51	7	group	group	NOUN
iajs-3516	51	8	probability	probability	NOUN
iajs-3516	51	9	high	high	ADJ
iajs-3516	51	10	moderate	moderate	ADJ
iajs-3516	51	11	total	total	ADJ
iajs-3516	51	12	9	9	NUM
iajs-3516	51	13	(	(	PUNCT
iajs-3516	51	14	34.62	34.62	NUM
iajs-3516	51	15	)	)	PUNCT
iajs-3516	51	16	17	17	NUM
iajs-3516	51	17	(	(	PUNCT
iajs-3516	51	18	65.38	65.38	NUM
iajs-3516	51	19	)	)	PUNCT
iajs-3516	51	20	26	26	NUM
iajs-3516	51	21	(	(	PUNCT
iajs-3516	51	22	100.0	100.0	NUM
iajs-3516	51	23	)	)	PUNCT
iajs-3516	51	24	0.027	0.027	NUM
iajs-3516	51	25	*	*	PUNCT
iajs-3516	51	26	χ2	χ2	NOUN
iajs-3516	51	27	test	test	NOUN
iajs-3516	51	28	*	*	PUNCT
iajs-3516	51	29	is	be	AUX
iajs-3516	51	30	significant	significant	ADJ
iajs-3516	51	31	at	at	ADP
iajs-3516	51	32	p	p	NOUN
iajs-3516	51	33	≤	≤	NUM
iajs-3516	51	34	0.05	0.05	NUM
iajs-3516	51	35	.	.	PUNCT
iajs-3516	52	1	4	4	NUM
iajs-3516	52	2	.	.	X
iajs-3516	52	3	discussion	discussion	NOUN
iajs-3516	52	4	tables	table	NOUN
iajs-3516	52	5	(	(	PUNCT
iajs-3516	52	6	1	1	NUM
iajs-3516	52	7	)	)	PUNCT
iajs-3516	52	8	and	and	CCONJ
iajs-3516	52	9	(	(	PUNCT
iajs-3516	52	10	2	2	X
iajs-3516	52	11	)	)	PUNCT
iajs-3516	52	12	showed	show	VERB
iajs-3516	52	13	that	that	SCONJ
iajs-3516	52	14	there	there	PRON
iajs-3516	52	15	were	be	VERB
iajs-3516	52	16	no	no	DET
iajs-3516	52	17	significant	significant	ADJ
iajs-3516	52	18	differences	difference	NOUN
iajs-3516	52	19	between	between	ADP
iajs-3516	52	20	patients	patient	NOUN
iajs-3516	52	21	and	and	CCONJ
iajs-3516	52	22	controls	control	NOUN
iajs-3516	52	23	in	in	ADP
iajs-3516	52	24	infecting	infect	VERB
iajs-3516	52	25	with	with	ADP
iajs-3516	52	26	ebv	ebv	NOUN
iajs-3516	52	27	-	-	PUNCT
iajs-3516	52	28	vca	vca	PROPN
iajs-3516	52	29	and	and	CCONJ
iajs-3516	52	30	ebna	ebna	NOUN
iajs-3516	52	31	.	.	PUNCT
iajs-3516	53	1	these	these	DET
iajs-3516	53	2	results	result	NOUN
iajs-3516	53	3	agree	agree	VERB
iajs-3516	53	4	with	with	ADP
iajs-3516	53	5	(	(	PUNCT
iajs-3516	53	6	12	12	NUM
iajs-3516	53	7	)	)	PUNCT
iajs-3516	53	8	;	;	PUNCT
iajs-3516	53	9	the	the	DET
iajs-3516	53	10	number	number	NOUN
iajs-3516	53	11	of	of	ADP
iajs-3516	53	12	patients	patient	NOUN
iajs-3516	53	13	with	with	ADP
iajs-3516	53	14	a	a	DET
iajs-3516	53	15	positive	positive	ADJ
iajs-3516	53	16	ebv	ebv	NOUN
iajs-3516	53	17	viral	viral	ADJ
iajs-3516	53	18	load	load	NOUN
iajs-3516	53	19	did	do	AUX
iajs-3516	53	20	not	not	PART
iajs-3516	53	21	vary	vary	VERB
iajs-3516	53	22	between	between	ADP
iajs-3516	53	23	groups	group	NOUN
iajs-3516	53	24	:	:	PUNCT
iajs-3516	53	25	80	80	NUM
iajs-3516	53	26	%	%	NOUN
iajs-3516	53	27	of	of	ADP
iajs-3516	53	28	people	people	NOUN
iajs-3516	53	29	in	in	ADP
iajs-3516	53	30	the	the	DET
iajs-3516	53	31	control	control	NOUN
iajs-3516	53	32	group	group	NOUN
iajs-3516	53	33	,	,	PUNCT
iajs-3516	53	34	65	65	NUM
iajs-3516	53	35	%	%	NOUN
iajs-3516	53	36	of	of	ADP
iajs-3516	53	37	people	people	NOUN
iajs-3516	53	38	with	with	ADP
iajs-3516	53	39	pondylarthropathy	pondylarthropathy	NOUN
iajs-3516	53	40	(	(	PUNCT
iajs-3516	53	41	spa	spa	NOUN
iajs-3516	53	42	)	)	PUNCT
iajs-3516	53	43	,	,	PUNCT
iajs-3516	53	44	79	79	NUM
iajs-3516	53	45	%	%	NOUN
iajs-3516	53	46	of	of	ADP
iajs-3516	53	47	people	people	NOUN
iajs-3516	53	48	with	with	ADP
iajs-3516	53	49	ra	ra	PROPN
iajs-3516	53	50	who	who	PRON
iajs-3516	53	51	were	be	AUX
iajs-3516	53	52	taking	take	VERB
iajs-3516	53	53	methotrexate	methotrexate	NOUN
iajs-3516	53	54	(	(	PUNCT
iajs-3516	53	55	mtx	mtx	NOUN
iajs-3516	53	56	)	)	PUNCT
iajs-3516	53	57	,	,	PUNCT
iajs-3516	53	58	and	and	CCONJ
iajs-3516	53	59	85	85	NUM
iajs-3516	53	60	%	%	NOUN
iajs-3516	53	61	of	of	ADP
iajs-3516	53	62	people	people	NOUN
iajs-3516	53	63	with	with	ADP
iajs-3516	53	64	ra	ra	PROPN
iajs-3516	53	65	who	who	PRON
iajs-3516	53	66	were	be	AUX
iajs-3516	53	67	not	not	PART
iajs-3516	53	68	taking	take	VERB
iajs-3516	53	69	disease	disease	NOUN
iajs-3516	53	70	-	-	PUNCT
iajs-3516	53	71	modifying	modify	VERB
iajs-3516	53	72	anti	anti	ADJ
iajs-3516	53	73	-	-	ADJ
iajs-3516	53	74	rheumatic	rheumatic	ADJ
iajs-3516	53	75	drugs	drug	NOUN
iajs-3516	53	76	(	(	PUNCT
iajs-3516	53	77	dmards	dmard	NOUN
iajs-3516	53	78	)	)	PUNCT
iajs-3516	53	79	(	(	PUNCT
iajs-3516	53	80	p	p	X
iajs-3516	53	81	=	=	NOUN
iajs-3516	53	82	0.42	0.42	NUM
iajs-3516	53	83	)	)	PUNCT
iajs-3516	53	84	.	.	PUNCT
iajs-3516	54	1	ball	ball	NOUN
iajs-3516	54	2	et	et	PROPN
iajs-3516	54	3	al	al	PROPN
iajs-3516	54	4	.	.	PROPN
iajs-3516	54	5	showed	show	VERB
iajs-3516	54	6	that	that	SCONJ
iajs-3516	54	7	there	there	PRON
iajs-3516	54	8	is	be	VERB
iajs-3516	54	9	no	no	DET
iajs-3516	54	10	link	link	NOUN
iajs-3516	54	11	between	between	ADP
iajs-3516	54	12	ebv	ebv	NOUN
iajs-3516	54	13	seroprevalence	seroprevalence	NOUN
iajs-3516	54	14	and	and	CCONJ
iajs-3516	54	15	ra	ra	NOUN
iajs-3516	54	16	.	.	PUNCT
iajs-3516	55	1	this	this	PRON
iajs-3516	55	2	means	mean	VERB
iajs-3516	55	3	that	that	SCONJ
iajs-3516	55	4	the	the	DET
iajs-3516	55	5	hypothesis	hypothesis	NOUN
iajs-3516	55	6	that	that	PRON
iajs-3516	55	7	a	a	DET
iajs-3516	55	8	previous	previous	ADJ
iajs-3516	55	9	infection	infection	NOUN
iajs-3516	55	10	with	with	ADP
iajs-3516	55	11	ebv	ebv	NOUN
iajs-3516	55	12	makes	make	VERB
iajs-3516	55	13	you	you	PRON
iajs-3516	55	14	more	more	ADV
iajs-3516	55	15	likely	likely	ADJ
iajs-3516	55	16	to	to	PART
iajs-3516	55	17	get	get	VERB
iajs-3516	55	18	ra	ra	PROPN
iajs-3516	55	19	is	be	AUX
iajs-3516	55	20	not	not	PART
iajs-3516	55	21	true	true	ADJ
iajs-3516	55	22	.	.	PUNCT
iajs-3516	56	1	in	in	ADP
iajs-3516	56	2	contrast	contrast	NOUN
iajs-3516	56	3	,	,	PUNCT
iajs-3516	56	4	a	a	DET
iajs-3516	56	5	meta	meta	ADJ
iajs-3516	56	6	-	-	PUNCT
iajs-3516	56	7	analysis	analysis	NOUN
iajs-3516	56	8	showed	show	VERB
iajs-3516	56	9	that	that	SCONJ
iajs-3516	56	10	ebv	ebv	NOUN
iajs-3516	56	11	infection	infection	NOUN
iajs-3516	56	12	is	be	AUX
iajs-3516	56	13	linked	link	VERB
iajs-3516	56	14	to	to	ADP
iajs-3516	56	15	multiple	multiple	ADJ
iajs-3516	56	16	sclerosis	sclerosis	NOUN
iajs-3516	56	17	and	and	CCONJ
iajs-3516	56	18	sle	sle	PROPN
iajs-3516	56	19	(	(	PUNCT
iajs-3516	56	20	8)	8)	NUM
iajs-3516	56	21	.	.	PUNCT
iajs-3516	57	1	the	the	DET
iajs-3516	57	2	study	study	NOUN
iajs-3516	57	3	disagreed	disagree	VERB
iajs-3516	57	4	with	with	ADP
iajs-3516	57	5	some	some	DET
iajs-3516	57	6	studies	study	NOUN
iajs-3516	57	7	(	(	PUNCT
iajs-3516	57	8	13item	13item	NUM
iajs-3516	57	9	ebna	ebna	PROPN
iajs-3516	57	10	results	result	NOUN
iajs-3516	57	11	no	no	INTJ
iajs-3516	57	12	.	.	PUNCT
iajs-3516	58	1	(	(	PUNCT
iajs-3516	58	2	%	%	INTJ
iajs-3516	58	3	)	)	PUNCT
iajs-3516	58	4	probability	probability	NOUN
iajs-3516	58	5	patients	patient	NOUN
iajs-3516	58	6	group	group	PROPN
iajs-3516	58	7	control	control	PROPN
iajs-3516	58	8	group	group	PROPN
iajs-3516	58	9	positive	positive	ADJ
iajs-3516	58	10	negative	negative	ADJ
iajs-3516	58	11	total	total	ADJ
iajs-3516	58	12	26	26	NUM
iajs-3516	58	13	(	(	PUNCT
iajs-3516	58	14	57.8	57.8	NUM
iajs-3516	58	15	)	)	SYM
iajs-3516	58	16	19	19	NUM
iajs-3516	58	17	(	(	PUNCT
iajs-3516	58	18	42.2	42.2	NUM
iajs-3516	58	19	)	)	PUNCT
iajs-3516	58	20	45	45	NUM
iajs-3516	58	21	(	(	PUNCT
iajs-3516	58	22	100.0	100.0	NUM
iajs-3516	58	23	)	)	PUNCT
iajs-3516	58	24	23	23	NUM
iajs-3516	58	25	(	(	PUNCT
iajs-3516	58	26	51.1	51.1	NUM
iajs-3516	58	27	)	)	PUNCT
iajs-3516	58	28	22	22	NUM
iajs-3516	58	29	(	(	PUNCT
iajs-3516	58	30	48.9	48.9	NUM
iajs-3516	58	31	)	)	PUNCT
iajs-3516	58	32	45	45	NUM
iajs-3516	58	33	(	(	PUNCT
iajs-3516	58	34	100.0	100.0	NUM
iajs-3516	58	35	)	)	PUNCT
iajs-3516	58	36	0.525	0.525	NUM
iajs-3516	58	37	ihjpas	ihjpa	NOUN
iajs-3516	58	38	.	.	PUNCT
iajs-3516	59	1	2025	2025	NUM
iajs-3516	59	2	,	,	PUNCT
iajs-3516	59	3	38(3	38(3	NUM
iajs-3516	59	4	)	)	PUNCT
iajs-3516	59	5	4	4	NUM
iajs-3516	59	6	15	15	NUM
iajs-3516	59	7	)	)	PUNCT
iajs-3516	59	8	that	that	PRON
iajs-3516	59	9	indicated	indicate	VERB
iajs-3516	59	10	that	that	SCONJ
iajs-3516	59	11	there	there	PRON
iajs-3516	59	12	are	be	VERB
iajs-3516	59	13	significant	significant	ADJ
iajs-3516	59	14	differences	difference	NOUN
iajs-3516	59	15	in	in	ADP
iajs-3516	59	16	ra	ra	PROPN
iajs-3516	59	17	patients	patient	NOUN
iajs-3516	59	18	;	;	PUNCT
iajs-3516	59	19	ebv	ebv	NOUN
iajs-3516	59	20	was	be	AUX
iajs-3516	59	21	higher	high	ADJ
iajs-3516	59	22	than	than	ADP
iajs-3516	59	23	that	that	PRON
iajs-3516	59	24	in	in	ADP
iajs-3516	59	25	the	the	DET
iajs-3516	59	26	control	control	NOUN
iajs-3516	59	27	group	group	NOUN
iajs-3516	59	28	.	.	PUNCT
iajs-3516	60	1	the	the	DET
iajs-3516	60	2	explanation	explanation	NOUN
iajs-3516	60	3	of	of	ADP
iajs-3516	60	4	the	the	DET
iajs-3516	60	5	current	current	ADJ
iajs-3516	60	6	results	result	NOUN
iajs-3516	60	7	may	may	AUX
iajs-3516	60	8	be	be	AUX
iajs-3516	60	9	due	due	ADJ
iajs-3516	60	10	to	to	ADP
iajs-3516	60	11	the	the	DET
iajs-3516	60	12	seroprevalence	seroprevalence	NOUN
iajs-3516	60	13	of	of	ADP
iajs-3516	60	14	ebv	ebv	NOUN
iajs-3516	60	15	rising	rise	VERB
iajs-3516	60	16	with	with	ADP
iajs-3516	60	17	age	age	NOUN
iajs-3516	60	18	,	,	PUNCT
iajs-3516	60	19	going	go	VERB
iajs-3516	60	20	from	from	ADP
iajs-3516	60	21	69.9	69.9	NUM
iajs-3516	60	22	%	%	NOUN
iajs-3516	60	23	in	in	ADP
iajs-3516	60	24	the	the	DET
iajs-3516	60	25	age	age	NOUN
iajs-3516	60	26	category	category	NOUN
iajs-3516	60	27	of	of	ADP
iajs-3516	60	28	1–4.9	1–4.9	NUM
iajs-3516	60	29	years	year	NOUN
iajs-3516	60	30	old	old	ADJ
iajs-3516	60	31	to	to	ADP
iajs-3516	60	32	96.0	96.0	NUM
iajs-3516	60	33	%	%	NOUN
iajs-3516	60	34	in	in	ADP
iajs-3516	60	35	the	the	DET
iajs-3516	60	36	age	age	NOUN
iajs-3516	60	37	range	range	NOUN
iajs-3516	60	38	of	of	ADP
iajs-3516	60	39	20–25	20–25	NUM
iajs-3516	60	40	years	year	NOUN
iajs-3516	60	41	old	old	ADJ
iajs-3516	60	42	(	(	PUNCT
iajs-3516	60	43	16	16	NUM
iajs-3516	60	44	)	)	PUNCT
iajs-3516	60	45	,	,	PUNCT
iajs-3516	60	46	especially	especially	ADV
iajs-3516	60	47	since	since	SCONJ
iajs-3516	60	48	all	all	DET
iajs-3516	60	49	the	the	DET
iajs-3516	60	50	samples	sample	NOUN
iajs-3516	60	51	in	in	ADP
iajs-3516	60	52	this	this	DET
iajs-3516	60	53	study	study	NOUN
iajs-3516	60	54	were	be	AUX
iajs-3516	60	55	adults	adult	NOUN
iajs-3516	60	56	.	.	PUNCT
iajs-3516	61	1	most	most	ADJ
iajs-3516	61	2	people	people	NOUN
iajs-3516	61	3	are	be	AUX
iajs-3516	61	4	susceptible	susceptible	ADJ
iajs-3516	61	5	to	to	ADP
iajs-3516	61	6	ebv	ebv	NOUN
iajs-3516	61	7	at	at	ADP
iajs-3516	61	8	some	some	DET
iajs-3516	61	9	point	point	NOUN
iajs-3516	61	10	in	in	ADP
iajs-3516	61	11	their	their	PRON
iajs-3516	61	12	life	life	NOUN
iajs-3516	61	13	,	,	PUNCT
iajs-3516	61	14	and	and	CCONJ
iajs-3516	61	15	the	the	DET
iajs-3516	61	16	virus	virus	NOUN
iajs-3516	61	17	is	be	AUX
iajs-3516	61	18	widespread	widespread	ADJ
iajs-3516	61	19	.	.	PUNCT
iajs-3516	62	1	saliva	saliva	NOUN
iajs-3516	62	2	is	be	AUX
iajs-3516	62	3	the	the	DET
iajs-3516	62	4	primary	primary	ADJ
iajs-3516	62	5	vehicle	vehicle	NOUN
iajs-3516	62	6	for	for	ADP
iajs-3516	62	7	the	the	DET
iajs-3516	62	8	transmission	transmission	NOUN
iajs-3516	62	9	of	of	ADP
iajs-3516	62	10	ebv	ebv	NOUN
iajs-3516	62	11	(	(	PUNCT
iajs-3516	62	12	17	17	NUM
iajs-3516	62	13	)	)	PUNCT
iajs-3516	62	14	.	.	PUNCT
iajs-3516	63	1	most	most	ADJ
iajs-3516	63	2	adults	adult	NOUN
iajs-3516	63	3	and	and	CCONJ
iajs-3516	63	4	adolescents	adolescent	NOUN
iajs-3516	63	5	who	who	PRON
iajs-3516	63	6	contract	contract	VERB
iajs-3516	63	7	ebv	ebv	NOUN
iajs-3516	63	8	and	and	CCONJ
iajs-3516	63	9	experience	experience	NOUN
iajs-3516	63	10	symptoms	symptom	NOUN
iajs-3516	63	11	recover	recover	VERB
iajs-3516	63	12	completely	completely	ADV
iajs-3516	63	13	within	within	ADP
iajs-3516	63	14	a	a	DET
iajs-3516	63	15	month	month	NOUN
iajs-3516	63	16	.	.	PUNCT
iajs-3516	64	1	but	but	CCONJ
iajs-3516	64	2	for	for	ADP
iajs-3516	64	3	some	some	PRON
iajs-3516	64	4	,	,	PUNCT
iajs-3516	64	5	exhaustion	exhaustion	NOUN
iajs-3516	64	6	might	might	AUX
iajs-3516	64	7	last	last	VERB
iajs-3516	64	8	for	for	ADP
iajs-3516	64	9	months	month	NOUN
iajs-3516	64	10	at	at	ADP
iajs-3516	64	11	a	a	DET
iajs-3516	64	12	time	time	NOUN
iajs-3516	64	13	(	(	PUNCT
iajs-3516	64	14	18	18	NUM
iajs-3516	64	15	)	)	PUNCT
iajs-3516	64	16	.	.	PUNCT
iajs-3516	65	1	the	the	DET
iajs-3516	65	2	ebv	ebv	PROPN
iajs-3516	65	3	virus	virus	NOUN
iajs-3516	65	4	,	,	PUNCT
iajs-3516	65	5	once	once	ADV
iajs-3516	65	6	infected	infect	VERB
iajs-3516	65	7	,	,	PUNCT
iajs-3516	65	8	goes	go	VERB
iajs-3516	65	9	dormant	dormant	ADJ
iajs-3516	65	10	(	(	PUNCT
iajs-3516	65	11	inactive	inactive	ADJ
iajs-3516	65	12	)	)	PUNCT
iajs-3516	65	13	in	in	ADP
iajs-3516	65	14	the	the	DET
iajs-3516	65	15	host	host	NOUN
iajs-3516	65	16	's	's	PART
iajs-3516	65	17	body	body	NOUN
iajs-3516	65	18	(	(	PUNCT
iajs-3516	65	19	19	19	NUM
iajs-3516	65	20	)	)	PUNCT
iajs-3516	65	21	.	.	PUNCT
iajs-3516	66	1	the	the	DET
iajs-3516	66	2	virus	virus	NOUN
iajs-3516	66	3	can	can	AUX
iajs-3516	66	4	reactivate	reactivate	VERB
iajs-3516	66	5	itself	itself	PRON
iajs-3516	66	6	in	in	ADP
iajs-3516	66	7	some	some	DET
iajs-3516	66	8	people	people	NOUN
iajs-3516	66	9	.	.	PUNCT
iajs-3516	67	1	reactivation	reactivation	NOUN
iajs-3516	67	2	of	of	ADP
iajs-3516	67	3	ebv	ebv	NOUN
iajs-3516	67	4	may	may	AUX
iajs-3516	67	5	not	not	PART
iajs-3516	67	6	necessarily	necessarily	ADV
iajs-3516	67	7	result	result	VERB
iajs-3516	67	8	in	in	ADP
iajs-3516	67	9	symptoms	symptom	NOUN
iajs-3516	67	10	,	,	PUNCT
iajs-3516	67	11	although	although	SCONJ
iajs-3516	67	12	those	those	PRON
iajs-3516	67	13	with	with	ADP
iajs-3516	67	14	compromised	compromise	VERB
iajs-3516	67	15	immune	immune	ADJ
iajs-3516	67	16	systems	system	NOUN
iajs-3516	67	17	are	be	AUX
iajs-3516	67	18	likely	likely	ADJ
iajs-3516	67	19	to	to	PART
iajs-3516	67	20	experience	experience	VERB
iajs-3516	67	21	them	they	PRON
iajs-3516	67	22	(	(	PUNCT
iajs-3516	67	23	20	20	NUM
iajs-3516	67	24	)	)	PUNCT
iajs-3516	67	25	.	.	PUNCT
iajs-3516	68	1	the	the	DET
iajs-3516	68	2	phenomenon	phenomenon	NOUN
iajs-3516	68	3	of	of	ADP
iajs-3516	68	4	molecular	molecular	ADJ
iajs-3516	68	5	mimicry	mimicry	NOUN
iajs-3516	68	6	is	be	AUX
iajs-3516	68	7	the	the	DET
iajs-3516	68	8	mechanism	mechanism	NOUN
iajs-3516	68	9	that	that	PRON
iajs-3516	68	10	is	be	AUX
iajs-3516	68	11	cited	cite	VERB
iajs-3516	68	12	the	the	DET
iajs-3516	68	13	most	most	ADV
iajs-3516	68	14	frequently	frequently	ADV
iajs-3516	68	15	in	in	ADP
iajs-3516	68	16	order	order	NOUN
iajs-3516	68	17	to	to	PART
iajs-3516	68	18	explain	explain	VERB
iajs-3516	68	19	autoimmune	autoimmune	ADJ
iajs-3516	68	20	diseases	disease	NOUN
iajs-3516	68	21	that	that	PRON
iajs-3516	68	22	occur	occur	VERB
iajs-3516	68	23	after	after	ADP
iajs-3516	68	24	infections	infection	NOUN
iajs-3516	68	25	(	(	PUNCT
iajs-3516	68	26	21	21	NUM
iajs-3516	68	27	)	)	PUNCT
iajs-3516	68	28	.	.	PUNCT
iajs-3516	69	1	this	this	DET
iajs-3516	69	2	study	study	NOUN
iajs-3516	69	3	is	be	AUX
iajs-3516	69	4	in	in	ADP
iajs-3516	69	5	agreement	agreement	NOUN
iajs-3516	69	6	with	with	ADP
iajs-3516	69	7	this	this	DET
iajs-3516	69	8	mechanism	mechanism	NOUN
iajs-3516	69	9	.	.	PUNCT
iajs-3516	70	1	on	on	ADP
iajs-3516	70	2	the	the	DET
iajs-3516	70	3	other	other	ADJ
iajs-3516	70	4	hand	hand	NOUN
iajs-3516	70	5	,	,	PUNCT
iajs-3516	70	6	both	both	CCONJ
iajs-3516	70	7	the	the	DET
iajs-3516	70	8	hypothesis	hypothesis	NOUN
iajs-3516	70	9	that	that	PRON
iajs-3516	70	10	ebv	ebv	NOUN
iajs-3516	70	11	immortalizes	immortalize	VERB
iajs-3516	70	12	self	self	NOUN
iajs-3516	70	13	-	-	PUNCT
iajs-3516	70	14	reactive	reactive	ADJ
iajs-3516	70	15	b	b	NOUN
iajs-3516	70	16	cells	cell	NOUN
iajs-3516	70	17	that	that	PRON
iajs-3516	70	18	would	would	AUX
iajs-3516	70	19	otherwise	otherwise	ADV
iajs-3516	70	20	be	be	AUX
iajs-3516	70	21	deleted	delete	VERB
iajs-3516	70	22	and	and	CCONJ
iajs-3516	70	23	the	the	DET
iajs-3516	70	24	idea	idea	NOUN
iajs-3516	70	25	that	that	SCONJ
iajs-3516	70	26	ebv	ebv	NOUN
iajs-3516	70	27	resets	reset	VERB
iajs-3516	70	28	the	the	DET
iajs-3516	70	29	global	global	ADJ
iajs-3516	70	30	immune	immune	ADJ
iajs-3516	70	31	system	system	NOUN
iajs-3516	70	32	to	to	ADP
iajs-3516	70	33	a	a	DET
iajs-3516	70	34	more	more	ADV
iajs-3516	70	35	active	active	ADJ
iajs-3516	70	36	state	state	NOUN
iajs-3516	70	37	imply	imply	VERB
iajs-3516	70	38	that	that	SCONJ
iajs-3516	70	39	ebv	ebv	NOUN
iajs-3516	70	40	infection	infection	NOUN
iajs-3516	70	41	should	should	AUX
iajs-3516	70	42	cause	cause	VERB
iajs-3516	70	43	a	a	DET
iajs-3516	70	44	genetic	genetic	ADJ
iajs-3516	70	45	predisposition	predisposition	NOUN
iajs-3516	70	46	to	to	ADP
iajs-3516	70	47	autoimmune	autoimmune	ADJ
iajs-3516	70	48	disease	disease	NOUN
iajs-3516	70	49	,	,	PUNCT
iajs-3516	70	50	which	which	PRON
iajs-3516	70	51	is	be	AUX
iajs-3516	70	52	difficult	difficult	ADJ
iajs-3516	70	53	to	to	PART
iajs-3516	70	54	reconcile	reconcile	VERB
iajs-3516	70	55	with	with	ADP
iajs-3516	70	56	the	the	DET
iajs-3516	70	57	findings	finding	NOUN
iajs-3516	70	58	of	of	ADP
iajs-3516	70	59	the	the	DET
iajs-3516	70	60	present	present	ADJ
iajs-3516	70	61	study	study	NOUN
iajs-3516	70	62	(	(	PUNCT
iajs-3516	70	63	22	22	NUM
iajs-3516	70	64	)	)	PUNCT
iajs-3516	70	65	.	.	PUNCT
iajs-3516	71	1	two	two	NUM
iajs-3516	71	2	further	further	ADJ
iajs-3516	71	3	mechanisms	mechanism	NOUN
iajs-3516	71	4	suggested	suggest	VERB
iajs-3516	71	5	explaining	explain	VERB
iajs-3516	71	6	the	the	DET
iajs-3516	71	7	associations	association	NOUN
iajs-3516	71	8	are	be	AUX
iajs-3516	71	9	mistaken	mistaken	ADJ
iajs-3516	71	10	self	self	NOUN
iajs-3516	71	11	and	and	CCONJ
iajs-3516	71	12	bystander	bystander	NOUN
iajs-3516	71	13	damage	damage	NOUN
iajs-3516	71	14	surrounding	surround	VERB
iajs-3516	71	15	ebv	ebv	NOUN
iajs-3516	71	16	reactivation	reactivation	NOUN
iajs-3516	71	17	,	,	PUNCT
iajs-3516	71	18	both	both	PRON
iajs-3516	71	19	of	of	ADP
iajs-3516	71	20	which	which	PRON
iajs-3516	71	21	are	be	AUX
iajs-3516	71	22	consistent	consistent	ADJ
iajs-3516	71	23	with	with	ADP
iajs-3516	71	24	the	the	DET
iajs-3516	71	25	disease	disease	NOUN
iajs-3516	71	26	associations	association	NOUN
iajs-3516	71	27	being	be	AUX
iajs-3516	71	28	confined	confine	VERB
iajs-3516	71	29	to	to	ADP
iajs-3516	71	30	specific	specific	ADJ
iajs-3516	71	31	diseases	disease	NOUN
iajs-3516	71	32	(	(	PUNCT
iajs-3516	71	33	9	9	NUM
iajs-3516	71	34	,	,	PUNCT
iajs-3516	71	35	23	23	NUM
iajs-3516	71	36	,	,	PUNCT
iajs-3516	71	37	24	24	NUM
iajs-3516	71	38	)	)	PUNCT
iajs-3516	71	39	.	.	PUNCT
iajs-3516	72	1	to	to	PART
iajs-3516	72	2	measure	measure	VERB
iajs-3516	72	3	the	the	DET
iajs-3516	72	4	activity	activity	NOUN
iajs-3516	72	5	of	of	ADP
iajs-3516	72	6	the	the	DET
iajs-3516	72	7	disease	disease	NOUN
iajs-3516	72	8	,	,	PUNCT
iajs-3516	72	9	a	a	DET
iajs-3516	72	10	variety	variety	NOUN
iajs-3516	72	11	of	of	ADP
iajs-3516	72	12	composite	composite	ADJ
iajs-3516	72	13	scales	scale	NOUN
iajs-3516	72	14	are	be	AUX
iajs-3516	72	15	available	available	ADJ
iajs-3516	72	16	.	.	PUNCT
iajs-3516	73	1	some	some	DET
iajs-3516	73	2	examples	example	NOUN
iajs-3516	73	3	of	of	ADP
iajs-3516	73	4	these	these	DET
iajs-3516	73	5	scales	scale	NOUN
iajs-3516	73	6	include	include	VERB
iajs-3516	73	7	the	the	DET
iajs-3516	73	8	disease	disease	NOUN
iajs-3516	73	9	activity	activity	NOUN
iajs-3516	73	10	score	score	NOUN
iajs-3516	73	11	utilizing	utilize	VERB
iajs-3516	73	12	28	28	NUM
iajs-3516	73	13	joints	joint	NOUN
iajs-3516	73	14	(	(	PUNCT
iajs-3516	73	15	das-28	das-28	PROPN
iajs-3516	73	16	)	)	PUNCT
iajs-3516	73	17	,	,	PUNCT
iajs-3516	73	18	the	the	DET
iajs-3516	73	19	simplified	simplified	ADJ
iajs-3516	73	20	disease	disease	NOUN
iajs-3516	73	21	activity	activity	NOUN
iajs-3516	73	22	assessment	assessment	NOUN
iajs-3516	73	23	index	index	NOUN
iajs-3516	73	24	(	(	PUNCT
iajs-3516	73	25	sdai	sdai	PROPN
iajs-3516	73	26	)	)	PUNCT
iajs-3516	73	27	,	,	PUNCT
iajs-3516	73	28	and	and	CCONJ
iajs-3516	73	29	the	the	DET
iajs-3516	73	30	clinical	clinical	ADJ
iajs-3516	73	31	disease	disease	NOUN
iajs-3516	73	32	assessment	assessment	NOUN
iajs-3516	73	33	index	index	NOUN
iajs-3516	73	34	(	(	PUNCT
iajs-3516	73	35	cdai	cdai	NOUN
iajs-3516	73	36	)	)	PUNCT
iajs-3516	73	37	(	(	PUNCT
iajs-3516	73	38	2	2	NUM
iajs-3516	73	39	)	)	PUNCT
iajs-3516	73	40	.	.	PUNCT
iajs-3516	74	1	the	the	DET
iajs-3516	74	2	significant	significant	ADJ
iajs-3516	74	3	differences	difference	NOUN
iajs-3516	74	4	in	in	ADP
iajs-3516	74	5	tables	table	NOUN
iajs-3516	74	6	(	(	PUNCT
iajs-3516	74	7	3	3	NUM
iajs-3516	74	8	)	)	PUNCT
iajs-3516	74	9	and	and	CCONJ
iajs-3516	74	10	(	(	PUNCT
iajs-3516	74	11	4	4	X
iajs-3516	74	12	)	)	PUNCT
iajs-3516	74	13	in	in	ADP
iajs-3516	74	14	high	high	ADJ
iajs-3516	74	15	and	and	CCONJ
iajs-3516	74	16	moderate	moderate	ADJ
iajs-3516	74	17	ra	ra	PROPN
iajs-3516	74	18	disease	disease	NOUN
iajs-3516	74	19	activity	activity	NOUN
iajs-3516	74	20	infected	infect	VERB
iajs-3516	74	21	with	with	ADP
iajs-3516	74	22	the	the	DET
iajs-3516	74	23	virus	virus	NOUN
iajs-3516	74	24	return	return	VERB
iajs-3516	74	25	to	to	ADP
iajs-3516	74	26	the	the	DET
iajs-3516	74	27	fact	fact	NOUN
iajs-3516	74	28	that	that	SCONJ
iajs-3516	74	29	most	most	ADJ
iajs-3516	74	30	of	of	ADP
iajs-3516	74	31	the	the	DET
iajs-3516	74	32	collected	collect	VERB
iajs-3516	74	33	ra	ra	PROPN
iajs-3516	74	34	patients	patient	NOUN
iajs-3516	74	35	were	be	AUX
iajs-3516	74	36	in	in	ADP
iajs-3516	74	37	the	the	DET
iajs-3516	74	38	moderate	moderate	ADJ
iajs-3516	74	39	stage	stage	NOUN
iajs-3516	74	40	of	of	ADP
iajs-3516	74	41	the	the	DET
iajs-3516	74	42	disease	disease	NOUN
iajs-3516	74	43	.	.	PUNCT
iajs-3516	75	1	it	it	PRON
iajs-3516	75	2	's	be	AUX
iajs-3516	75	3	important	important	ADJ
iajs-3516	75	4	to	to	PART
iajs-3516	75	5	note	note	VERB
iajs-3516	75	6	that	that	SCONJ
iajs-3516	75	7	the	the	DET
iajs-3516	75	8	lack	lack	NOUN
iajs-3516	75	9	of	of	ADP
iajs-3516	75	10	a	a	DET
iajs-3516	75	11	link	link	NOUN
iajs-3516	75	12	between	between	ADP
iajs-3516	75	13	ebv	ebv	NOUN
iajs-3516	75	14	antibodies	antibody	NOUN
iajs-3516	75	15	and	and	CCONJ
iajs-3516	75	16	ra	ra	PROPN
iajs-3516	75	17	does	do	AUX
iajs-3516	75	18	n't	not	PART
iajs-3516	75	19	mean	mean	VERB
iajs-3516	75	20	that	that	SCONJ
iajs-3516	75	21	ebv	ebv	NOUN
iajs-3516	75	22	does	do	AUX
iajs-3516	75	23	n't	not	PART
iajs-3516	75	24	play	play	VERB
iajs-3516	75	25	a	a	DET
iajs-3516	75	26	role	role	NOUN
iajs-3516	75	27	in	in	ADP
iajs-3516	75	28	the	the	DET
iajs-3516	75	29	disease	disease	NOUN
iajs-3516	75	30	,	,	PUNCT
iajs-3516	75	31	as	as	SCONJ
iajs-3516	75	32	there	there	PRON
iajs-3516	75	33	is	be	VERB
iajs-3516	75	34	other	other	ADJ
iajs-3516	75	35	evidence	evidence	NOUN
iajs-3516	75	36	of	of	ADP
iajs-3516	75	37	this	this	PRON
iajs-3516	75	38	(	(	PUNCT
iajs-3516	75	39	25	25	NUM
iajs-3516	75	40	,	,	PUNCT
iajs-3516	75	41	26	26	NUM
iajs-3516	75	42	)	)	PUNCT
iajs-3516	75	43	.	.	PUNCT
iajs-3516	76	1	5	5	X
iajs-3516	76	2	.	.	X
iajs-3516	76	3	conclusion	conclusion	NOUN
iajs-3516	76	4	these	these	DET
iajs-3516	76	5	findings	finding	NOUN
iajs-3516	76	6	do	do	AUX
iajs-3516	76	7	not	not	PART
iajs-3516	76	8	reveal	reveal	VERB
iajs-3516	76	9	a	a	DET
iajs-3516	76	10	significant	significant	ADJ
iajs-3516	76	11	relationship	relationship	NOUN
iajs-3516	76	12	between	between	ADP
iajs-3516	76	13	ebv	ebv	NOUN
iajs-3516	76	14	seroprevalence	seroprevalence	NOUN
iajs-3516	76	15	and	and	CCONJ
iajs-3516	76	16	ra	ra	NOUN
iajs-3516	76	17	,	,	PUNCT
iajs-3516	76	18	and	and	CCONJ
iajs-3516	76	19	as	as	ADP
iajs-3516	76	20	a	a	DET
iajs-3516	76	21	result	result	NOUN
iajs-3516	76	22	,	,	PUNCT
iajs-3516	76	23	they	they	PRON
iajs-3516	76	24	do	do	AUX
iajs-3516	76	25	not	not	PART
iajs-3516	76	26	support	support	VERB
iajs-3516	76	27	the	the	DET
iajs-3516	76	28	concept	concept	NOUN
iajs-3516	76	29	that	that	SCONJ
iajs-3516	76	30	a	a	DET
iajs-3516	76	31	previous	previous	ADJ
iajs-3516	76	32	infection	infection	NOUN
iajs-3516	76	33	with	with	ADP
iajs-3516	76	34	ebv	ebv	NOUN
iajs-3516	76	35	predisposes	predispose	NOUN
iajs-3516	76	36	individuals	individual	NOUN
iajs-3516	76	37	to	to	ADP
iajs-3516	76	38	the	the	DET
iajs-3516	76	39	development	development	NOUN
iajs-3516	76	40	of	of	ADP
iajs-3516	76	41	ra	ra	PROPN
iajs-3516	76	42	.	.	PUNCT
iajs-3516	77	1	acknowledgment	acknowledgment	PROPN
iajs-3516	77	2	i	i	PRON
iajs-3516	77	3	’d	’d	NOUN
iajs-3516	77	4	like	like	VERB
iajs-3516	77	5	to	to	PART
iajs-3516	77	6	express	express	VERB
iajs-3516	77	7	my	my	PRON
iajs-3516	77	8	warmest	warm	ADJ
iajs-3516	77	9	gratitude	gratitude	NOUN
iajs-3516	77	10	and	and	CCONJ
iajs-3516	77	11	indebtedness	indebtedness	NOUN
iajs-3516	77	12	to	to	ADP
iajs-3516	77	13	the	the	DET
iajs-3516	77	14	staff	staff	NOUN
iajs-3516	77	15	of	of	ADP
iajs-3516	77	16	rheumatology	rheumatology	NOUN
iajs-3516	77	17	unit	unit	NOUN
iajs-3516	77	18	in	in	ADP
iajs-3516	77	19	baghdad	baghdad	PROPN
iajs-3516	77	20	hospital	hospital	NOUN
iajs-3516	77	21	.	.	PUNCT
iajs-3516	78	1	conflict	conflict	NOUN
iajs-3516	78	2	of	of	ADP
iajs-3516	78	3	interest	interest	NOUN
iajs-3516	78	4	the	the	DET
iajs-3516	78	5	authors	author	NOUN
iajs-3516	78	6	declare	declare	VERB
iajs-3516	78	7	that	that	SCONJ
iajs-3516	78	8	they	they	PRON
iajs-3516	78	9	have	have	VERB
iajs-3516	78	10	no	no	DET
iajs-3516	78	11	conflicts	conflict	NOUN
iajs-3516	78	12	of	of	ADP
iajs-3516	78	13	interest	interest	NOUN
iajs-3516	78	14	.	.	PUNCT
iajs-3516	79	1	funding	fund	VERB
iajs-3516	79	2	none	none	NOUN
iajs-3516	79	3	.	.	PUNCT
iajs-3516	80	1	ihjpas	ihjpas	PROPN
iajs-3516	80	2	.	.	PUNCT
iajs-3516	81	1	2025	2025	NUM
iajs-3516	81	2	,	,	PUNCT
iajs-3516	81	3	38(3	38(3	NUM
iajs-3516	81	4	)	)	PUNCT
iajs-3516	81	5	5	5	NUM
iajs-3516	81	6	ethical	ethical	ADJ
iajs-3516	81	7	clearance	clearance	NOUN
iajs-3516	81	8	this	this	DET
iajs-3516	81	9	study	study	NOUN
iajs-3516	81	10	was	be	AUX
iajs-3516	81	11	approved	approve	VERB
iajs-3516	81	12	by	by	ADP
iajs-3516	81	13	baghdad	baghdad	PROPN
iajs-3516	81	14	university	university	PROPN
iajs-3516	81	15	/	/	SYM
iajs-3516	81	16	college	college	PROPN
iajs-3516	81	17	of	of	ADP
iajs-3516	81	18	science	science	PROPN
iajs-3516	81	19	ethics	ethic	NOUN
iajs-3516	81	20	committee	committee	PROPN
iajs-3516	81	21	(	(	PUNCT
iajs-3516	81	22	ref	ref	NOUN
iajs-3516	81	23	:	:	PUNCT
iajs-3516	81	24	csec/0922/0079	csec/0922/0079	PROPN
iajs-3516	81	25	)	)	PUNCT
iajs-3516	81	26	.	.	PUNCT
iajs-3516	82	1	everyone	everyone	PRON
iajs-3516	82	2	signed	sign	VERB
iajs-3516	82	3	a	a	DET
iajs-3516	82	4	study	study	NOUN
iajs-3516	82	5	-	-	PUNCT
iajs-3516	82	6	related	relate	VERB
iajs-3516	82	7	informed	informed	ADJ
iajs-3516	82	8	consent	consent	NOUN
iajs-3516	82	9	.	.	PUNCT
iajs-3516	83	1	in	in	ADP
iajs-3516	83	2	compliance	compliance	NOUN
iajs-3516	83	3	with	with	ADP
iajs-3516	83	4	the	the	DET
iajs-3516	83	5	helsinki	helsinki	PROPN
iajs-3516	83	6	declaration	declaration	PROPN
iajs-3516	83	7	,	,	PUNCT
iajs-3516	83	8	all	all	DET
iajs-3516	83	9	human	human	ADJ
iajs-3516	83	10	rights	right	NOUN
iajs-3516	83	11	have	have	AUX
iajs-3516	83	12	been	be	AUX
iajs-3516	83	13	observed	observe	VERB
iajs-3516	83	14	.	.	PUNCT
iajs-3516	84	1	references	reference	NOUN
iajs-3516	84	2	1	1	NUM
iajs-3516	84	3	.	.	PUNCT
iajs-3516	84	4	salloom	salloom	PROPN
iajs-3516	84	5	df	df	PROPN
iajs-3516	84	6	,	,	PUNCT
iajs-3516	84	7	fadhil	fadhil	PROPN
iajs-3516	84	8	hy	hy	PROPN
iajs-3516	84	9	,	,	PUNCT
iajs-3516	84	10	abbas	abbas	PROPN
iajs-3516	84	11	ah	ah	INTJ
iajs-3516	84	12	.	.	PUNCT
iajs-3516	85	1	evaluation	evaluation	NOUN
iajs-3516	85	2	of	of	ADP
iajs-3516	85	3	leptin	leptin	NOUN
iajs-3516	85	4	in	in	ADP
iajs-3516	85	5	sera	sera	NOUN
iajs-3516	85	6	of	of	ADP
iajs-3516	85	7	a	a	DET
iajs-3516	85	8	sample	sample	NOUN
iajs-3516	85	9	of	of	ADP
iajs-3516	85	10	rheumatoid	rheumatoid	NOUN
iajs-3516	85	11	arthritis	arthritis	NOUN
iajs-3516	85	12	of	of	ADP
iajs-3516	85	13	iraqi	iraqi	ADJ
iajs-3516	85	14	patients	patient	NOUN
iajs-3516	85	15	.	.	PUNCT
iajs-3516	86	1	int	int	NOUN
iajs-3516	86	2	j	j	PROPN
iajs-3516	86	3	recent	recent	ADJ
iajs-3516	86	4	scient	scient	NOUN
iajs-3516	86	5	res	re	NOUN
iajs-3516	86	6	.	.	PUNCT
iajs-3516	87	1	2013;4(4):004–005	2013;4(4):004–005	NUM
iajs-3516	87	2	.	.	X
iajs-3516	87	3	2	2	NUM
iajs-3516	87	4	.	.	X
iajs-3516	87	5	guo	guo	PROPN
iajs-3516	87	6	q	q	PROPN
iajs-3516	87	7	,	,	PUNCT
iajs-3516	87	8	wang	wang	PROPN
iajs-3516	87	9	y	y	PROPN
iajs-3516	87	10	,	,	PUNCT
iajs-3516	87	11	xu	xu	PROPN
iajs-3516	88	1	d	d	PROPN
iajs-3516	88	2	,	,	PUNCT
iajs-3516	88	3	nossent	nossent	PROPN
iajs-3516	88	4	j	j	PROPN
iajs-3516	88	5	,	,	PUNCT
iajs-3516	88	6	pavlos	pavlos	PROPN
iajs-3516	88	7	nj	nj	PROPN
iajs-3516	88	8	,	,	PUNCT
iajs-3516	88	9	xu	xu	PROPN
iajs-3516	88	10	j.	j.	PROPN
iajs-3516	88	11	rheumatoid	rheumatoid	PROPN
iajs-3516	88	12	arthritis	arthritis	NOUN
iajs-3516	88	13	:	:	PUNCT
iajs-3516	88	14	pathological	pathological	ADJ
iajs-3516	88	15	mechanisms	mechanism	NOUN
iajs-3516	88	16	and	and	CCONJ
iajs-3516	88	17	modern	modern	ADJ
iajs-3516	88	18	pharmacologic	pharmacologic	ADJ
iajs-3516	88	19	therapies	therapy	NOUN
iajs-3516	88	20	.	.	PUNCT
iajs-3516	89	1	bone	bone	NOUN
iajs-3516	89	2	res	re	NOUN
iajs-3516	89	3	.	.	PUNCT
iajs-3516	89	4	2018;6:15	2018;6:15	NOUN
iajs-3516	89	5	.	.	PUNCT
iajs-3516	90	1	https://doi.org/10.1038/s41413-018-00169	https://doi.org/10.1038/s41413-018-00169	PROPN
iajs-3516	90	2	3	3	X
iajs-3516	90	3	.	.	X
iajs-3516	90	4	khayon	khayon	VERB
iajs-3516	90	5	lh	lh	PROPN
iajs-3516	90	6	,	,	PUNCT
iajs-3516	90	7	farhan	farhan	PROPN
iajs-3516	90	8	aa	aa	PROPN
iajs-3516	90	9	,	,	PUNCT
iajs-3516	90	10	salloom	salloom	NOUN
iajs-3516	90	11	df	df	PROPN
iajs-3516	90	12	.	.	PUNCT
iajs-3516	90	13	association	association	PROPN
iajs-3516	90	14	of	of	ADP
iajs-3516	90	15	interleukin-12b	interleukin-12b	PROPN
iajs-3516	90	16	polymorphism	polymorphism	NOUN
iajs-3516	90	17	and	and	CCONJ
iajs-3516	90	18	serum	serum	NOUN
iajs-3516	90	19	level	level	NOUN
iajs-3516	90	20	of	of	ADP
iajs-3516	90	21	interleukin-12	interleukin-12	PROPN
iajs-3516	90	22	in	in	ADP
iajs-3516	90	23	a	a	DET
iajs-3516	90	24	sample	sample	NOUN
iajs-3516	90	25	of	of	ADP
iajs-3516	90	26	iraqi	iraqi	ADJ
iajs-3516	90	27	patients	patient	NOUN
iajs-3516	90	28	with	with	ADP
iajs-3516	90	29	rheumatoid	rheumatoid	NOUN
iajs-3516	90	30	arthritis	arthritis	NOUN
iajs-3516	90	31	.	.	PUNCT
iajs-3516	91	1	egypt	egypt	PROPN
iajs-3516	91	2	j	j	PROPN
iajs-3516	91	3	hosp	hosp	PROPN
iajs-3516	91	4	med	med	PROPN
iajs-3516	91	5	.	.	PUNCT
iajs-3516	92	1	2023;90(2):2071–2073	2023;90(2):2071–2073	NOUN
iajs-3516	92	2	.	.	PUNCT
iajs-3516	93	1	https://doi.org/10.21608/ejhm.2023.285034	https://doi.org/10.21608/ejhm.2023.285034	PROPN
iajs-3516	93	2	4	4	NUM
iajs-3516	93	3	.	.	PUNCT
iajs-3516	93	4	ahmed	ahmed	PROPN
iajs-3516	93	5	dm	dm	PROPN
iajs-3516	93	6	,	,	PUNCT
iajs-3516	93	7	salloom	salloom	NOUN
iajs-3516	93	8	df	df	PROPN
iajs-3516	93	9	.	.	PUNCT
iajs-3516	94	1	the	the	DET
iajs-3516	94	2	association	association	NOUN
iajs-3516	94	3	between	between	ADP
iajs-3516	94	4	toll	toll	NOUN
iajs-3516	94	5	-	-	PUNCT
iajs-3516	94	6	like	like	ADJ
iajs-3516	94	7	receptor	receptor	NOUN
iajs-3516	94	8	7	7	NUM
iajs-3516	94	9	and	and	CCONJ
iajs-3516	94	10	hepatitis	hepatitis	PROPN
iajs-3516	94	11	c	c	PROPN
iajs-3516	94	12	virus	virus	NOUN
iajs-3516	94	13	in	in	ADP
iajs-3516	94	14	a	a	DET
iajs-3516	94	15	sample	sample	NOUN
iajs-3516	94	16	of	of	ADP
iajs-3516	94	17	iraqi	iraqi	ADJ
iajs-3516	94	18	rheumatoid	rheumatoid	NOUN
iajs-3516	94	19	arthritis	arthritis	NOUN
iajs-3516	94	20	patients	patient	NOUN
iajs-3516	94	21	.	.	PUNCT
iajs-3516	95	1	j	j	PROPN
iajs-3516	95	2	global	global	PROPN
iajs-3516	95	3	pharma	pharma	PROPN
iajs-3516	95	4	technol	technol	NOUN
iajs-3516	95	5	.	.	PUNCT
iajs-3516	96	1	2018;10(11	2018;10(11	NUM
iajs-3516	96	2	suppl):01–08	suppl):01–08	NOUN
iajs-3516	96	3	.	.	PUNCT
iajs-3516	97	1	5	5	X
iajs-3516	97	2	.	.	X
iajs-3516	97	3	nazar	nazar	PROPN
iajs-3516	97	4	la	la	PROPN
iajs-3516	97	5	,	,	PUNCT
iajs-3516	97	6	abass	abass	PROPN
iajs-3516	97	7	ea	ea	PROPN
iajs-3516	97	8	.	.	PUNCT
iajs-3516	98	1	study	study	NOUN
iajs-3516	98	2	of	of	ADP
iajs-3516	98	3	il-33	il-33	NOUN
iajs-3516	98	4	and	and	CCONJ
iajs-3516	98	5	il-1r4	il-1r4	NOUN
iajs-3516	98	6	in	in	ADP
iajs-3516	98	7	iraqi	iraqi	ADJ
iajs-3516	98	8	rheumatoid	rheumatoid	NOUN
iajs-3516	98	9	arthritis	arthritis	ADJ
iajs-3516	98	10	female	female	ADJ
iajs-3516	98	11	patients	patient	NOUN
iajs-3516	98	12	with	with	ADP
iajs-3516	98	13	and	and	CCONJ
iajs-3516	98	14	without	without	ADP
iajs-3516	98	15	dyslipidemia	dyslipidemia	NOUN
iajs-3516	98	16	prone	prone	ADJ
iajs-3516	98	17	to	to	ADP
iajs-3516	98	18	atherosclerosis	atherosclerosis	NOUN
iajs-3516	98	19	.	.	PUNCT
iajs-3516	99	1	ibn	ibn	PROPN
iajs-3516	99	2	al	al	PROPN
iajs-3516	99	3	-	-	PUNCT
iajs-3516	99	4	haitham	haitham	PROPN
iajs-3516	99	5	j	j	PROPN
iajs-3516	99	6	pure	pure	PROPN
iajs-3516	99	7	appl	appl	PROPN
iajs-3516	99	8	sci	sci	PROPN
iajs-3516	99	9	.	.	PUNCT
iajs-3516	100	1	2019;32(1):48–56	2019;32(1):48–56	NUM
iajs-3516	100	2	.	.	PUNCT
iajs-3516	101	1	https://doi.org/10.30526/32.1.1920	https://doi.org/10.30526/32.1.1920	PROPN
iajs-3516	101	2	6	6	NUM
iajs-3516	101	3	.	.	PUNCT
iajs-3516	102	1	costenbader	costenbader	PROPN
iajs-3516	102	2	kh	kh	PROPN
iajs-3516	102	3	,	,	PUNCT
iajs-3516	102	4	karlson	karlson	PROPN
iajs-3516	102	5	ew	ew	PROPN
iajs-3516	102	6	.	.	PROPN
iajs-3516	102	7	epstein	epstein	PROPN
iajs-3516	102	8	–	–	PUNCT
iajs-3516	102	9	barr	barr	PROPN
iajs-3516	102	10	virus	virus	PROPN
iajs-3516	102	11	and	and	CCONJ
iajs-3516	102	12	rheumatoid	rheumatoid	VERB
iajs-3516	102	13	arthritis	arthritis	NOUN
iajs-3516	102	14	:	:	PUNCT
iajs-3516	102	15	is	be	AUX
iajs-3516	102	16	there	there	PRON
iajs-3516	102	17	a	a	DET
iajs-3516	102	18	link	link	NOUN
iajs-3516	102	19	?	?	PUNCT
iajs-3516	103	1	arthritis	arthritis	NOUN
iajs-3516	103	2	res	re	NOUN
iajs-3516	103	3	therap	therap	NOUN
iajs-3516	103	4	.	.	PUNCT
iajs-3516	104	1	2006;8:204	2006;8:204	NUM
iajs-3516	104	2	.	.	PUNCT
iajs-3516	105	1	https://doi.org/10.1186/ar1893	https://doi.org/10.1186/ar1893	ADP
iajs-3516	105	2	7	7	NUM
iajs-3516	105	3	.	.	X
iajs-3516	105	4	ali	ali	PROPN
iajs-3516	105	5	s	s	PROPN
iajs-3516	105	6	,	,	PUNCT
iajs-3516	105	7	salloom	salloom	NOUN
iajs-3516	105	8	df	df	PROPN
iajs-3516	105	9	.	.	PUNCT
iajs-3516	106	1	a	a	DET
iajs-3516	106	2	novel	novel	ADJ
iajs-3516	106	3	finding	finding	NOUN
iajs-3516	106	4	of	of	ADP
iajs-3516	106	5	interleukin-9	interleukin-9	PROPN
iajs-3516	106	6	genetic	genetic	ADJ
iajs-3516	106	7	polymorphism	polymorphism	NOUN
iajs-3516	106	8	(	(	PUNCT
iajs-3516	106	9	rs17317275	rs17317275	PROPN
iajs-3516	106	10	)	)	PUNCT
iajs-3516	106	11	and	and	CCONJ
iajs-3516	106	12	serum	serum	NOUN
iajs-3516	106	13	level	level	NOUN
iajs-3516	106	14	in	in	ADP
iajs-3516	106	15	rheumatoid	rheumatoid	NOUN
iajs-3516	106	16	arthritis	arthritis	NOUN
iajs-3516	106	17	patients	patient	NOUN
iajs-3516	106	18	infected	infect	VERB
iajs-3516	106	19	with	with	ADP
iajs-3516	106	20	cmv	cmv	NOUN
iajs-3516	106	21	.	.	PUNCT
iajs-3516	107	1	plant	plant	NOUN
iajs-3516	107	2	arch	arch	NOUN
iajs-3516	107	3	.	.	PUNCT
iajs-3516	108	1	2020;20(suppl	2020;20(suppl	PROPN
iajs-3516	108	2	1):582–587	1):582–587	NUM
iajs-3516	108	3	.	.	PUNCT
iajs-3516	108	4	8	8	NUM
iajs-3516	108	5	.	.	PUNCT
iajs-3516	109	1	al	al	PROPN
iajs-3516	109	2	-	-	PUNCT
iajs-3516	109	3	bayati	bayati	PROPN
iajs-3516	109	4	oh	oh	INTJ
iajs-3516	109	5	,	,	PUNCT
iajs-3516	109	6	abood	abood	PROPN
iajs-3516	109	7	wn	wn	PROPN
iajs-3516	109	8	,	,	PUNCT
iajs-3516	109	9	salloom	salloom	NOUN
iajs-3516	109	10	df	df	PROPN
iajs-3516	109	11	.	.	PUNCT
iajs-3516	109	12	detection	detection	NOUN
iajs-3516	109	13	of	of	ADP
iajs-3516	109	14	epstein	epstein	PROPN
iajs-3516	109	15	–	–	PUNCT
iajs-3516	109	16	barr	barr	PROPN
iajs-3516	109	17	virus	virus	PROPN
iajs-3516	109	18	infection	infection	NOUN
iajs-3516	109	19	in	in	ADP
iajs-3516	109	20	reactive	reactive	ADJ
iajs-3516	109	21	arthritis	arthritis	NOUN
iajs-3516	109	22	patients	patient	NOUN
iajs-3516	109	23	.	.	PUNCT
iajs-3516	110	1	iraqi	iraqi	PROPN
iajs-3516	110	2	j	j	PROPN
iajs-3516	110	3	sci	sci	PROPN
iajs-3516	110	4	.	.	PUNCT
iajs-3516	110	5	2020;61(10):2479–2485	2020;61(10):2479–2485	PROPN
iajs-3516	110	6	.	.	PUNCT
iajs-3516	110	7	https://doi.org/10.1128/jb.179.15.4919-4928.1997	https://doi.org/10.1128/jb.179.15.4919-4928.1997	NOUN
iajs-3516	110	8	9	9	NUM
iajs-3516	110	9	.	.	PUNCT
iajs-3516	110	10	ball	ball	PROPN
iajs-3516	110	11	rj	rj	PROPN
iajs-3516	110	12	,	,	PUNCT
iajs-3516	110	13	avenell	avenell	PROPN
iajs-3516	110	14	a	a	X
iajs-3516	110	15	,	,	PUNCT
iajs-3516	110	16	aucott	aucott	PROPN
iajs-3516	110	17	l	l	PROPN
iajs-3516	110	18	,	,	PUNCT
iajs-3516	110	19	et	et	PROPN
iajs-3516	110	20	al	al	PROPN
iajs-3516	110	21	.	.	PUNCT
iajs-3516	110	22	systematic	systematic	PROPN
iajs-3516	110	23	review	review	NOUN
iajs-3516	110	24	and	and	CCONJ
iajs-3516	110	25	meta	meta	NOUN
iajs-3516	110	26	-	-	PUNCT
iajs-3516	110	27	analysis	analysis	NOUN
iajs-3516	110	28	of	of	ADP
iajs-3516	110	29	the	the	DET
iajs-3516	110	30	sero	sero	ADJ
iajs-3516	110	31	-	-	PUNCT
iajs-3516	110	32	epidemiological	epidemiological	ADJ
iajs-3516	110	33	association	association	NOUN
iajs-3516	110	34	between	between	ADP
iajs-3516	110	35	epstein	epstein	PROPN
iajs-3516	110	36	–	–	PUNCT
iajs-3516	110	37	barr	barr	PROPN
iajs-3516	110	38	virus	virus	PROPN
iajs-3516	110	39	and	and	CCONJ
iajs-3516	110	40	rheumatoid	rheumatoid	VERB
iajs-3516	110	41	arthritis	arthritis	NOUN
iajs-3516	110	42	.	.	PUNCT
iajs-3516	111	1	arthritis	arthritis	NOUN
iajs-3516	111	2	res	re	NOUN
iajs-3516	111	3	therap	therap	NOUN
iajs-3516	111	4	.	.	PUNCT
iajs-3516	112	1	2015;17:274	2015;17:274	NUM
iajs-3516	112	2	.	.	PUNCT
iajs-3516	112	3	https://doi.org/10.1186/s13075-015-0755-6	https://doi.org/10.1186/s13075-015-0755-6	NUM
iajs-3516	112	4	10	10	NUM
iajs-3516	112	5	.	.	PUNCT
iajs-3516	113	1	jonsson	jonsson	PROPN
iajs-3516	113	2	a	a	PROPN
iajs-3516	113	3	,	,	PUNCT
iajs-3516	113	4	hjalmarsson	hjalmarsson	NOUN
iajs-3516	113	5	c	c	NOUN
iajs-3516	113	6	,	,	PUNCT
iajs-3516	113	7	falk	falk	NOUN
iajs-3516	113	8	p.	p.	NOUN
iajs-3516	113	9	levels	level	NOUN
iajs-3516	113	10	of	of	ADP
iajs-3516	113	11	matrix	matrix	NOUN
iajs-3516	113	12	metalloproteinases	metalloproteinase	NOUN
iajs-3516	113	13	differ	differ	VERB
iajs-3516	113	14	in	in	ADP
iajs-3516	113	15	plasma	plasma	NOUN
iajs-3516	113	16	and	and	CCONJ
iajs-3516	113	17	serum	serum	NOUN
iajs-3516	113	18	–	–	PUNCT
iajs-3516	113	19	aspects	aspect	NOUN
iajs-3516	113	20	regarding	regard	VERB
iajs-3516	113	21	analysis	analysis	NOUN
iajs-3516	113	22	of	of	ADP
iajs-3516	113	23	biological	biological	ADJ
iajs-3516	113	24	markers	marker	NOUN
iajs-3516	113	25	in	in	ADP
iajs-3516	113	26	cancer	cancer	NOUN
iajs-3516	113	27	.	.	PUNCT
iajs-3516	114	1	br	br	PROPN
iajs-3516	114	2	j	j	PROPN
iajs-3516	114	3	cancer	cancer	NOUN
iajs-3516	114	4	.	.	PUNCT
iajs-3516	115	1	2016;115:703–706	2016;115:703–706	NUM
iajs-3516	115	2	.	.	PUNCT
iajs-3516	116	1	https://doi.org/10.1038/bjc.2016.127	https://doi.org/10.1038/bjc.2016.127	NOUN
iajs-3516	116	2	11	11	NUM
iajs-3516	116	3	.	.	PUNCT
iajs-3516	116	4	sabnis	sabnis	PROPN
iajs-3516	116	5	rw	rw	PROPN
iajs-3516	116	6	.	.	PROPN
iajs-3516	116	7	handbook	handbook	NOUN
iajs-3516	116	8	of	of	ADP
iajs-3516	116	9	biological	biological	ADJ
iajs-3516	116	10	dyes	dye	NOUN
iajs-3516	116	11	and	and	CCONJ
iajs-3516	116	12	stains	stain	NOUN
iajs-3516	116	13	:	:	PUNCT
iajs-3516	116	14	synthesis	synthesis	NOUN
iajs-3516	116	15	and	and	CCONJ
iajs-3516	116	16	industrial	industrial	ADJ
iajs-3516	116	17	application	application	NOUN
iajs-3516	116	18	.	.	PUNCT
iajs-3516	117	1	hoboken	hoboken	PROPN
iajs-3516	117	2	(	(	PUNCT
iajs-3516	117	3	nj	nj	PROPN
iajs-3516	117	4	):	):	PUNCT
iajs-3516	117	5	wiley	wiley	PROPN
iajs-3516	117	6	;	;	PUNCT
iajs-3516	117	7	2010	2010	NUM
iajs-3516	117	8	.	.	PUNCT
iajs-3516	118	1	https://doi.org/10.1002/0471709085	https://doi.org/10.1002/0471709085	X
iajs-3516	118	2	12	12	NUM
iajs-3516	118	3	.	.	PUNCT
iajs-3516	119	1	miceli	miceli	PROPN
iajs-3516	119	2	-	-	PUNCT
iajs-3516	119	3	richard	richard	PROPN
iajs-3516	119	4	c	c	PROPN
iajs-3516	119	5	,	,	PUNCT
iajs-3516	119	6	gestermann	gestermann	PROPN
iajs-3516	119	7	n	n	CCONJ
iajs-3516	119	8	,	,	PUNCT
iajs-3516	119	9	amiel	amiel	PROPN
iajs-3516	119	10	c	c	PROPN
iajs-3516	119	11	,	,	PUNCT
iajs-3516	119	12	et	et	PROPN
iajs-3516	119	13	al	al	PROPN
iajs-3516	119	14	.	.	PROPN
iajs-3516	119	15	effect	effect	NOUN
iajs-3516	119	16	of	of	ADP
iajs-3516	119	17	methotrexate	methotrexate	NOUN
iajs-3516	119	18	and	and	CCONJ
iajs-3516	119	19	anti	anti	ADJ
iajs-3516	119	20	-	-	ADJ
iajs-3516	119	21	tnf	tnf	PROPN
iajs-3516	119	22	on	on	ADP
iajs-3516	119	23	epstein	epstein	PROPN
iajs-3516	119	24	–	–	PUNCT
iajs-3516	119	25	barr	barr	PROPN
iajs-3516	119	26	virus	virus	PROPN
iajs-3516	119	27	t	t	PROPN
iajs-3516	119	28	-	-	PUNCT
iajs-3516	119	29	cell	cell	NOUN
iajs-3516	119	30	response	response	NOUN
iajs-3516	119	31	and	and	CCONJ
iajs-3516	119	32	viral	viral	ADJ
iajs-3516	119	33	load	load	NOUN
iajs-3516	119	34	in	in	ADP
iajs-3516	119	35	patients	patient	NOUN
iajs-3516	119	36	with	with	ADP
iajs-3516	119	37	rheumatoid	rheumatoid	NOUN
iajs-3516	119	38	arthritis	arthritis	NOUN
iajs-3516	119	39	or	or	CCONJ
iajs-3516	119	40	spondylarthropathies	spondylarthropathie	NOUN
iajs-3516	119	41	.	.	PUNCT
iajs-3516	120	1	arthritis	arthritis	NOUN
iajs-3516	120	2	res	re	NOUN
iajs-3516	120	3	therap	therap	NOUN
iajs-3516	120	4	.	.	PUNCT
iajs-3516	121	1	2009;11(3	2009;11(3	NUM
iajs-3516	121	2	)	)	PUNCT
iajs-3516	121	3	.	.	PUNCT
iajs-3516	122	1	https://doi.org/10.1186/ar2708	https://doi.org/10.1186/ar2708	ADP
iajs-3516	123	1	13	13	NUM
iajs-3516	123	2	.	.	PUNCT
iajs-3516	124	1	hamid	hamid	PROPN
iajs-3516	124	2	za	za	PROPN
iajs-3516	124	3	.	.	PUNCT
iajs-3516	125	1	the	the	DET
iajs-3516	125	2	impact	impact	NOUN
iajs-3516	125	3	of	of	ADP
iajs-3516	125	4	hepatitis	hepatitis	PROPN
iajs-3516	125	5	b	b	PROPN
iajs-3516	125	6	virus	virus	PROPN
iajs-3516	125	7	and	and	CCONJ
iajs-3516	125	8	epstein	epstein	PROPN
iajs-3516	125	9	–	–	PUNCT
iajs-3516	125	10	barr	barr	PROPN
iajs-3516	125	11	virus	virus	PROPN
iajs-3516	125	12	in	in	ADP
iajs-3516	125	13	pathogenesis	pathogenesis	NOUN
iajs-3516	125	14	of	of	ADP
iajs-3516	125	15	rheumatoid	rheumatoid	NOUN
iajs-3516	125	16	arthritis	arthritis	NOUN
iajs-3516	125	17	.	.	PUNCT
iajs-3516	125	18	biomed	biome	VERB
iajs-3516	125	19	pharmacol	pharmacol	PROPN
iajs-3516	125	20	j.	j.	PROPN
iajs-3516	125	21	2017;10(3):1495–1501	2017;10(3):1495–1501	PROPN
iajs-3516	125	22	.	.	PUNCT
iajs-3516	126	1	14	14	NUM
iajs-3516	126	2	.	.	X
iajs-3516	126	3	jassim	jassim	PROPN
iajs-3516	126	4	ns	ns	NUM
iajs-3516	126	5	,	,	PUNCT
iajs-3516	126	6	aboud	aboud	NOUN
iajs-3516	126	7	rs	rs	NOUN
iajs-3516	126	8	,	,	PUNCT
iajs-3516	126	9	joda	joda	PROPN
iajs-3516	126	10	at	at	ADP
iajs-3516	126	11	.	.	PUNCT
iajs-3516	126	12	detection	detection	NOUN
iajs-3516	126	13	of	of	ADP
iajs-3516	126	14	epstein	epstein	PROPN
iajs-3516	126	15	–	–	PUNCT
iajs-3516	126	16	barr	barr	PROPN
iajs-3516	126	17	virus	virus	PROPN
iajs-3516	126	18	capsid	capsid	VERB
iajs-3516	126	19	antigen	antigen	NOUN
iajs-3516	126	20	(	(	PUNCT
iajs-3516	126	21	ebv	ebv	NOUN
iajs-3516	126	22	ca	ca	NOUN
iajs-3516	126	23	)	)	PUNCT
iajs-3516	126	24	in	in	ADP
iajs-3516	126	25	sera	sera	NOUN
iajs-3516	126	26	of	of	ADP
iajs-3516	126	27	rheumatoid	rheumatoid	NOUN
iajs-3516	126	28	arthritis	arthritis	NOUN
iajs-3516	126	29	,	,	PUNCT
iajs-3516	126	30	reactive	reactive	ADJ
iajs-3516	126	31	arthritis	arthritis	NOUN
iajs-3516	126	32	and	and	CCONJ
iajs-3516	126	33	ankylosing	ankylose	VERB
iajs-3516	126	34	spondylitis	spondylitis	ADJ
iajs-3516	126	35	patients	patient	NOUN
iajs-3516	126	36	.	.	PUNCT
iajs-3516	127	1	iraqi	iraqi	PROPN
iajs-3516	127	2	j	j	PROPN
iajs-3516	127	3	sci	sci	PROPN
iajs-3516	127	4	.	.	PUNCT
iajs-3516	128	1	2015;56(4b):3130–3134	2015;56(4b):3130–3134	NUM
iajs-3516	128	2	.	.	PUNCT
iajs-3516	128	3	15	15	NUM
iajs-3516	128	4	.	.	X
iajs-3516	128	5	jassim	jassim	PROPN
iajs-3516	128	6	ns	ns	NUM
iajs-3516	128	7	,	,	PUNCT
iajs-3516	128	8	aboud	aboud	NOUN
iajs-3516	128	9	rs	rs	NOUN
iajs-3516	128	10	,	,	PUNCT
iajs-3516	128	11	fadil	fadil	ADJ
iajs-3516	128	12	hy	hy	PROPN
iajs-3516	128	13	.	.	PUNCT
iajs-3516	129	1	detection	detection	NOUN
iajs-3516	129	2	of	of	ADP
iajs-3516	129	3	epstein	epstein	PROPN
iajs-3516	129	4	–	–	PUNCT
iajs-3516	129	5	barr	barr	PROPN
iajs-3516	129	6	virus	virus	PROPN
iajs-3516	129	7	infection	infection	NOUN
iajs-3516	129	8	in	in	ADP
iajs-3516	129	9	patients	patient	NOUN
iajs-3516	129	10	with	with	ADP
iajs-3516	129	11	arthritis	arthritis	NOUN
iajs-3516	129	12	by	by	ADP
iajs-3516	129	13	immunological	immunological	ADJ
iajs-3516	129	14	and	and	CCONJ
iajs-3516	129	15	molecular	molecular	ADJ
iajs-3516	129	16	methods	method	NOUN
iajs-3516	129	17	.	.	PUNCT
iajs-3516	130	1	med	med	PROPN
iajs-3516	130	2	j	j	PROPN
iajs-3516	130	3	sulaimani	sulaimani	PROPN
iajs-3516	130	4	.	.	PUNCT
iajs-3516	131	1	2016;27(2	2016;27(2	NUM
iajs-3516	131	2	)	)	PUNCT
iajs-3516	131	3	.	.	PUNCT
iajs-3516	132	1	https://doi.org/10.24996/ijs.2020.61.10.4	https://doi.org/10.24996/ijs.2020.61.10.4	X
iajs-3516	133	1	16	16	X
iajs-3516	133	2	.	.	PUNCT
iajs-3516	134	1	kuri	kuri	PROPN
iajs-3516	134	2	a	a	PROPN
iajs-3516	134	3	,	,	PUNCT
iajs-3516	134	4	jacobs	jacobs	PROPN
iajs-3516	134	5	bm	bm	PROPN
iajs-3516	134	6	,	,	PUNCT
iajs-3516	134	7	vickaryous	vickaryous	ADJ
iajs-3516	134	8	n.	n.	NOUN
iajs-3516	134	9	epidemiology	epidemiology	NOUN
iajs-3516	134	10	of	of	ADP
iajs-3516	134	11	epstein	epstein	PROPN
iajs-3516	134	12	–	–	PUNCT
iajs-3516	134	13	barr	barr	PROPN
iajs-3516	134	14	virus	virus	PROPN
iajs-3516	134	15	infection	infection	NOUN
iajs-3516	134	16	and	and	CCONJ
iajs-3516	134	17	infectious	infectious	ADJ
iajs-3516	134	18	mononucleosis	mononucleosis	NOUN
iajs-3516	134	19	in	in	ADP
iajs-3516	134	20	the	the	DET
iajs-3516	134	21	united	united	ADJ
iajs-3516	134	22	kingdom	kingdom	PROPN
iajs-3516	134	23	.	.	PUNCT
iajs-3516	135	1	bmc	bmc	ADJ
iajs-3516	135	2	public	public	ADJ
iajs-3516	135	3	health	health	NOUN
iajs-3516	135	4	.	.	PUNCT
iajs-3516	136	1	2020;20:912	2020;20:912	X
iajs-3516	136	2	.	.	PUNCT
iajs-3516	137	1	https://doi.org/10.1186/s12889-020-09049-x	https://doi.org/10.1186/s12889-020-09049-x	NOUN
iajs-3516	137	2	.	.	PUNCT
iajs-3516	138	1	https://doi.org/10.1038/s41413-018-0016-9	https://doi.org/10.1038/s41413-018-0016-9	NUM
iajs-3516	138	2	https://doi.org/10.1038/s41413-018-0016-9	https://doi.org/10.1038/s41413-018-0016-9	PROPN
iajs-3516	139	1	https://doi.org/10.21608/ejhm.2023.285034	https://doi.org/10.21608/ejhm.2023.285034	PROPN
iajs-3516	139	2	https://doi.org/10.30526/32.1.1920	https://doi.org/10.30526/32.1.1920	PROPN
iajs-3516	139	3	https://doi.org/10.1186/ar1893	https://doi.org/10.1186/ar1893	PRON
iajs-3516	139	4	https://doi.org/10.1128/jb.179.15.4919-4928.1997	https://doi.org/10.1128/jb.179.15.4919-4928.1997	NOUN
iajs-3516	139	5	https://doi.org/10.1186/s13075-015-0755-6	https://doi.org/10.1186/s13075-015-0755-6	PART
iajs-3516	139	6	https://doi.org/10.1038/bjc.2016.127	https://doi.org/10.1038/bjc.2016.127	NOUN
iajs-3516	139	7	https://doi.org/10.1002/0471709085	https://doi.org/10.1002/0471709085	X
iajs-3516	139	8	https://doi.org/10.1186/ar2708	https://doi.org/10.1186/ar2708	NOUN
iajs-3516	139	9	https://doi.org/10.24996/ijs.2020.61.10.4	https://doi.org/10.24996/ijs.2020.61.10.4	NUM
iajs-3516	140	1	https://doi.org/10.1186/s12889-020-09049-x	https://doi.org/10.1186/s12889-020-09049-x	PROPN
iajs-3516	140	2	ihjpas	ihjpas	PROPN
iajs-3516	140	3	.	.	PUNCT
iajs-3516	141	1	2025	2025	NUM
iajs-3516	141	2	,	,	PUNCT
iajs-3516	141	3	38(3	38(3	NUM
iajs-3516	141	4	)	)	PUNCT
iajs-3516	141	5	6	6	NUM
iajs-3516	141	6	17	17	NUM
iajs-3516	141	7	.	.	PUNCT
iajs-3516	142	1	damania	damania	PROPN
iajs-3516	142	2	b	b	PROPN
iajs-3516	142	3	,	,	PUNCT
iajs-3516	142	4	kenney	kenney	PROPN
iajs-3516	142	5	sc	sc	PROPN
iajs-3516	142	6	,	,	PUNCT
iajs-3516	142	7	raab	raab	PROPN
iajs-3516	142	8	-	-	PUNCT
iajs-3516	142	9	traub	traub	PROPN
iajs-3516	142	10	n.	n.	PROPN
iajs-3516	142	11	epstein	epstein	PROPN
iajs-3516	142	12	-	-	PUNCT
iajs-3516	142	13	barr	barr	PROPN
iajs-3516	142	14	virus	virus	PROPN
iajs-3516	142	15	:	:	PUNCT
iajs-3516	142	16	biology	biology	NOUN
iajs-3516	142	17	and	and	CCONJ
iajs-3516	142	18	clinical	clinical	ADJ
iajs-3516	142	19	disease	disease	NOUN
iajs-3516	142	20	.	.	PUNCT
iajs-3516	143	1	cell	cell	NOUN
iajs-3516	143	2	.	.	PUNCT
iajs-3516	144	1	2022;185(20):3652	2022;185(20):3652	NUM
iajs-3516	144	2	-	-	SYM
iajs-3516	144	3	3670	3670	NUM
iajs-3516	144	4	.	.	PUNCT
iajs-3516	145	1	https://doi.org/10.1016/j.cell.2022.08.026	https://doi.org/10.1016/j.cell.2022.08.026	PROPN
iajs-3516	145	2	.	.	PUNCT
iajs-3516	146	1	18	18	NUM
iajs-3516	146	2	.	.	PUNCT
iajs-3516	147	1	katz	katz	PROPN
iajs-3516	147	2	bz	bz	PROPN
iajs-3516	147	3	,	,	PUNCT
iajs-3516	147	4	shiraishi	shiraishi	PROPN
iajs-3516	147	5	y	y	PROPN
iajs-3516	147	6	,	,	PUNCT
iajs-3516	147	7	mears	mears	PROPN
iajs-3516	147	8	cj	cj	PROPN
iajs-3516	147	9	,	,	PUNCT
iajs-3516	147	10	binns	binns	PROPN
iajs-3516	147	11	hj	hj	PROPN
iajs-3516	147	12	,	,	PUNCT
iajs-3516	147	13	taylor	taylor	PROPN
iajs-3516	147	14	r.	r.	PROPN
iajs-3516	147	15	chronic	chronic	PROPN
iajs-3516	147	16	fatigue	fatigue	NOUN
iajs-3516	147	17	syndrome	syndrome	NOUN
iajs-3516	147	18	after	after	ADP
iajs-3516	147	19	infectious	infectious	ADJ
iajs-3516	147	20	mononucleosis	mononucleosis	NOUN
iajs-3516	147	21	in	in	ADP
iajs-3516	147	22	adolescents	adolescent	NOUN
iajs-3516	147	23	.	.	PUNCT
iajs-3516	148	1	pediatrics	pediatric	NOUN
iajs-3516	148	2	.	.	PUNCT
iajs-3516	149	1	2009;124(1):189	2009;124(1):189	NUM
iajs-3516	149	2	-	-	SYM
iajs-3516	149	3	193	193	NUM
iajs-3516	149	4	.	.	PUNCT
iajs-3516	150	1	https://doi.org/10.1542/peds.20081879	https://doi.org/10.1542/peds.20081879	VERB
iajs-3516	150	2	.	.	PUNCT
iajs-3516	151	1	19	19	NUM
iajs-3516	151	2	.	.	PUNCT
iajs-3516	152	1	huang	huang	PROPN
iajs-3516	152	2	w	w	PROPN
iajs-3516	152	3	,	,	PUNCT
iajs-3516	152	4	bai	bai	PROPN
iajs-3516	152	5	l	l	PROPN
iajs-3516	152	6	,	,	PUNCT
iajs-3516	152	7	tang	tang	PROPN
iajs-3516	152	8	h.	h.	PROPN
iajs-3516	152	9	epstein	epstein	PROPN
iajs-3516	152	10	-	-	PUNCT
iajs-3516	152	11	barr	barr	PROPN
iajs-3516	152	12	virus	virus	NOUN
iajs-3516	152	13	infection	infection	NOUN
iajs-3516	152	14	:	:	PUNCT
iajs-3516	152	15	the	the	DET
iajs-3516	152	16	micro	micro	ADJ
iajs-3516	152	17	and	and	CCONJ
iajs-3516	152	18	macro	macro	ADJ
iajs-3516	152	19	worlds	worlds	PROPN
iajs-3516	152	20	.	.	PUNCT
iajs-3516	153	1	virol	virol	PROPN
iajs-3516	153	2	j	j	PROPN
iajs-3516	153	3	,	,	PUNCT
iajs-3516	153	4	2023	2023	NUM
iajs-3516	153	5	;	;	PUNCT
iajs-3516	153	6	20	20	NUM
iajs-3516	153	7	:	:	SYM
iajs-3516	153	8	220	220	NUM
iajs-3516	153	9	.	.	PUNCT
iajs-3516	154	1	https://doi.org/10.1186/s12985-023-02187-9	https://doi.org/10.1186/s12985-023-02187-9	NOUN
iajs-3516	154	2	.	.	PUNCT
iajs-3516	155	1	20	20	NUM
iajs-3516	155	2	.	.	PUNCT
iajs-3516	155	3	sausen	sausen	PROPN
iajs-3516	155	4	dg	dg	PROPN
iajs-3516	155	5	,	,	PUNCT
iajs-3516	155	6	bhutta	bhutta	PROPN
iajs-3516	155	7	ms	ms	PROPN
iajs-3516	155	8	,	,	PUNCT
iajs-3516	155	9	gallo	gallo	PROPN
iajs-3516	155	10	es	es	PROPN
iajs-3516	155	11	,	,	PUNCT
iajs-3516	155	12	dahari	dahari	ADJ
iajs-3516	155	13	h	h	NOUN
iajs-3516	155	14	,	,	PUNCT
iajs-3516	155	15	borenstein	borenstein	PROPN
iajs-3516	155	16	r.	r.	PROPN
iajs-3516	155	17	stress	stress	PROPN
iajs-3516	155	18	-	-	PUNCT
iajs-3516	155	19	induced	induce	VERB
iajs-3516	155	20	epstein	epstein	PROPN
iajs-3516	155	21	-	-	PUNCT
iajs-3516	155	22	barr	barr	PROPN
iajs-3516	155	23	virus	virus	PROPN
iajs-3516	155	24	reactivation	reactivation	NOUN
iajs-3516	155	25	.	.	PUNCT
iajs-3516	156	1	biomolecules	biomolecule	NOUN
iajs-3516	156	2	.	.	PUNCT
iajs-3516	157	1	2021;11(9):1380	2021;11(9):1380	NUM
iajs-3516	157	2	.	.	PUNCT
iajs-3516	157	3	https://doi.org/10.3390/biom11091380	https://doi.org/10.3390/biom11091380	PROPN
iajs-3516	157	4	.	.	PUNCT
iajs-3516	158	1	21	21	NUM
iajs-3516	158	2	.	.	PUNCT
iajs-3516	159	1	cusick	cusick	PROPN
iajs-3516	159	2	mf	mf	PROPN
iajs-3516	159	3	,	,	PUNCT
iajs-3516	159	4	libbey	libbey	PROPN
iajs-3516	159	5	je	je	PROPN
iajs-3516	159	6	,	,	PUNCT
iajs-3516	159	7	fujinami	fujinami	ADJ
iajs-3516	159	8	rs	rs	NOUN
iajs-3516	159	9	.	.	PUNCT
iajs-3516	160	1	molecular	molecular	ADJ
iajs-3516	160	2	mimicry	mimicry	NOUN
iajs-3516	160	3	as	as	ADP
iajs-3516	160	4	a	a	DET
iajs-3516	160	5	mechanism	mechanism	NOUN
iajs-3516	160	6	of	of	ADP
iajs-3516	160	7	autoimmune	autoimmune	ADJ
iajs-3516	160	8	disease	disease	NOUN
iajs-3516	160	9	.	.	PUNCT
iajs-3516	161	1	clin	clin	PROPN
iajs-3516	161	2	rev	rev	PROPN
iajs-3516	161	3	allergy	allergy	PROPN
iajs-3516	161	4	immunol	immunol	PROPN
iajs-3516	161	5	.	.	PUNCT
iajs-3516	162	1	2012;42(1):102	2012;42(1):102	NUM
iajs-3516	162	2	-	-	SYM
iajs-3516	162	3	111	111	NUM
iajs-3516	162	4	.	.	PUNCT
iajs-3516	163	1	https://doi.org/10.1007/s12016-011-8294-7	https://doi.org/10.1007/s12016-011-8294-7	NUM
iajs-3516	163	2	.	.	PUNCT
iajs-3516	164	1	22	22	NUM
iajs-3516	164	2	.	.	PUNCT
iajs-3516	165	1	ortega	ortega	PROPN
iajs-3516	165	2	-	-	PROPN
iajs-3516	165	3	hernandez	hernandez	PROPN
iajs-3516	165	4	o	o	PROPN
iajs-3516	165	5	-	-	PROPN
iajs-3516	165	6	d	d	PROPN
iajs-3516	165	7	,	,	PUNCT
iajs-3516	165	8	martínez	martínez	NOUN
iajs-3516	165	9	-	-	PUNCT
iajs-3516	165	10	cáceres	cácere	VERB
iajs-3516	165	11	em	em	PRON
iajs-3516	165	12	,	,	PUNCT
iajs-3516	165	13	presas	presas	NOUN
iajs-3516	165	14	-	-	PUNCT
iajs-3516	165	15	rodríguez	rodríguez	NOUN
iajs-3516	165	16	s	s	NOUN
iajs-3516	165	17	,	,	PUNCT
iajs-3516	165	18	ramo	ramo	PROPN
iajs-3516	165	19	-	-	PUNCT
iajs-3516	165	20	tello	tello	PROPN
iajs-3516	165	21	c.	c.	PROPN
iajs-3516	165	22	epstein	epstein	PROPN
iajs-3516	165	23	-	-	PUNCT
iajs-3516	165	24	barr	barr	PROPN
iajs-3516	165	25	virus	virus	NOUN
iajs-3516	165	26	and	and	CCONJ
iajs-3516	165	27	multiple	multiple	ADJ
iajs-3516	165	28	sclerosis	sclerosis	NOUN
iajs-3516	165	29	:	:	PUNCT
iajs-3516	165	30	a	a	DET
iajs-3516	165	31	convoluted	convoluted	ADJ
iajs-3516	165	32	interaction	interaction	NOUN
iajs-3516	165	33	and	and	CCONJ
iajs-3516	165	34	the	the	DET
iajs-3516	165	35	opportunity	opportunity	NOUN
iajs-3516	165	36	to	to	PART
iajs-3516	165	37	unravel	unravel	VERB
iajs-3516	165	38	predictive	predictive	ADJ
iajs-3516	165	39	biomarkers	biomarker	NOUN
iajs-3516	165	40	.	.	PUNCT
iajs-3516	166	1	int	int	NOUN
iajs-3516	166	2	.	.	PUNCT
iajs-3516	167	1	j.	j.	PROPN
iajs-3516	167	2	mol	mol	PROPN
iajs-3516	167	3	.	.	PUNCT
iajs-3516	168	1	sci	sci	PROPN
iajs-3516	168	2	.	.	PUNCT
iajs-3516	169	1	2023;24(8):7407	2023;24(8):7407	NUM
iajs-3516	169	2	.	.	PUNCT
iajs-3516	170	1	https://doi.org/10.3390/ijms24087407	https://doi.org/10.3390/ijms24087407	PROPN
iajs-3516	170	2	.	.	PUNCT
iajs-3516	171	1	23	23	NUM
iajs-3516	171	2	.	.	PUNCT
iajs-3516	172	1	soldan	soldan	PROPN
iajs-3516	172	2	ss	ss	PROPN
iajs-3516	172	3	,	,	PUNCT
iajs-3516	172	4	lieberman	lieberman	PROPN
iajs-3516	172	5	pm	pm	PROPN
iajs-3516	172	6	.	.	PUNCT
iajs-3516	172	7	epstein	epstein	PROPN
iajs-3516	172	8	-	-	PUNCT
iajs-3516	172	9	barr	barr	PROPN
iajs-3516	172	10	virus	virus	PROPN
iajs-3516	172	11	infection	infection	NOUN
iajs-3516	172	12	in	in	ADP
iajs-3516	172	13	the	the	DET
iajs-3516	172	14	development	development	NOUN
iajs-3516	172	15	of	of	ADP
iajs-3516	172	16	neurological	neurological	ADJ
iajs-3516	172	17	disorders	disorder	NOUN
iajs-3516	172	18	.	.	PUNCT
iajs-3516	173	1	drug	drug	NOUN
iajs-3516	173	2	discov	discov	PROPN
iajs-3516	173	3	today	today	NOUN
iajs-3516	173	4	dis	dis	PROPN
iajs-3516	173	5	models	model	NOUN
iajs-3516	173	6	.	.	PUNCT
iajs-3516	174	1	2020;32(pt	2020;32(pt	PROPN
iajs-3516	174	2	a):35	a):35	PROPN
iajs-3516	174	3	-	-	PUNCT
iajs-3516	174	4	52	52	NUM
iajs-3516	174	5	.	.	PUNCT
iajs-3516	175	1	https://doi.org/10.1016/j.ddmod.2020.01.001	https://doi.org/10.1016/j.ddmod.2020.01.001	PROPN
iajs-3516	175	2	.	.	PUNCT
iajs-3516	176	1	24	24	NUM
iajs-3516	176	2	.	.	PUNCT
iajs-3516	177	1	thomas	thomas	PROPN
iajs-3516	177	2	og	og	PROPN
iajs-3516	177	3	,	,	PUNCT
iajs-3516	177	4	rickinson	rickinson	PROPN
iajs-3516	177	5	a	a	DET
iajs-3516	177	6	,	,	PUNCT
iajs-3516	177	7	palendira	palendira	PROPN
iajs-3516	177	8	u.	u.	PROPN
iajs-3516	177	9	epstein	epstein	PROPN
iajs-3516	177	10	-	-	PUNCT
iajs-3516	177	11	barr	barr	PROPN
iajs-3516	177	12	virus	virus	NOUN
iajs-3516	177	13	and	and	CCONJ
iajs-3516	177	14	multiple	multiple	ADJ
iajs-3516	177	15	sclerosis	sclerosis	NOUN
iajs-3516	177	16	:	:	PUNCT
iajs-3516	177	17	moving	move	VERB
iajs-3516	177	18	from	from	ADP
iajs-3516	177	19	questions	question	NOUN
iajs-3516	177	20	of	of	ADP
iajs-3516	177	21	association	association	NOUN
iajs-3516	177	22	to	to	ADP
iajs-3516	177	23	questions	question	NOUN
iajs-3516	177	24	of	of	ADP
iajs-3516	177	25	mechanism	mechanism	NOUN
iajs-3516	177	26	.	.	PUNCT
iajs-3516	178	1	clin	clin	PROPN
iajs-3516	178	2	transl	transl	PROPN
iajs-3516	178	3	immunol	immunol	NOUN
iajs-3516	178	4	.	.	PUNCT
iajs-3516	179	1	2023;12(5):e1451	2023;12(5):e1451	NUM
iajs-3516	179	2	.	.	PUNCT
iajs-3516	180	1	https://doi.org/10.1002/cti2.1451	https://doi.org/10.1002/cti2.1451	X
iajs-3516	180	2	.	.	PUNCT
iajs-3516	181	1	25	25	NUM
iajs-3516	181	2	.	.	PUNCT
iajs-3516	182	1	toussirot	toussirot	PROPN
iajs-3516	182	2	e	e	NOUN
iajs-3516	182	3	,	,	PUNCT
iajs-3516	182	4	roudier	roudi	ADJ
iajs-3516	182	5	j.	j.	PROPN
iajs-3516	182	6	epstein	epstein	PROPN
iajs-3516	182	7	–	–	PUNCT
iajs-3516	182	8	barr	barr	PROPN
iajs-3516	182	9	virus	virus	PROPN
iajs-3516	182	10	in	in	ADP
iajs-3516	182	11	autoimmune	autoimmune	ADJ
iajs-3516	182	12	diseases	disease	NOUN
iajs-3516	182	13	.	.	PUNCT
iajs-3516	183	1	best	good	ADJ
iajs-3516	183	2	prac	prac	PROPN
iajs-3516	183	3	res	re	NOUN
iajs-3516	183	4	clin	clin	PROPN
iajs-3516	183	5	rheumatol	rheumatol	NOUN
iajs-3516	183	6	.	.	PUNCT
iajs-3516	184	1	2008;22:883–896	2008;22:883–896	NOUN
iajs-3516	184	2	.	.	PUNCT
iajs-3516	185	1	https://doi.org/10.1016/j.berh.2008.09.007	https://doi.org/10.1016/j.berh.2008.09.007	PROPN
iajs-3516	185	2	.	.	PUNCT
iajs-3516	186	1	26	26	NUM
iajs-3516	186	2	.	.	X
iajs-3516	186	3	morawiec	morawiec	PROPN
iajs-3516	186	4	n	n	CCONJ
iajs-3516	186	5	,	,	PUNCT
iajs-3516	186	6	adamczyk	adamczyk	PROPN
iajs-3516	186	7	b	b	NUM
iajs-3516	186	8	,	,	PUNCT
iajs-3516	186	9	spyra	spyra	VERB
iajs-3516	186	10	a	a	PRON
iajs-3516	186	11	,	,	PUNCT
iajs-3516	186	12	herba	herba	PROPN
iajs-3516	186	13	m	m	PROPN
iajs-3516	186	14	,	,	PUNCT
iajs-3516	186	15	boczek	boczek	PROPN
iajs-3516	186	16	s	s	PROPN
iajs-3516	186	17	,	,	PUNCT
iajs-3516	186	18	korbel	korbel	NOUN
iajs-3516	186	19	n	n	CCONJ
iajs-3516	186	20	,	,	PUNCT
iajs-3516	186	21	polechoński	polechoński	ADJ
iajs-3516	186	22	p	p	NOUN
iajs-3516	186	23	,	,	PUNCT
iajs-3516	186	24	adamczyk	adamczyk	NOUN
iajs-3516	186	25	-	-	PUNCT
iajs-3516	186	26	sowa	sowa	NOUN
iajs-3516	186	27	m.	m.	NOUN
iajs-3516	186	28	the	the	DET
iajs-3516	186	29	role	role	NOUN
iajs-3516	186	30	of	of	ADP
iajs-3516	186	31	epstein	epstein	PROPN
iajs-3516	186	32	-	-	PUNCT
iajs-3516	186	33	barr	barr	PROPN
iajs-3516	186	34	virus	virus	NOUN
iajs-3516	186	35	in	in	ADP
iajs-3516	186	36	the	the	DET
iajs-3516	186	37	pathogenesis	pathogenesis	NOUN
iajs-3516	186	38	of	of	ADP
iajs-3516	186	39	autoimmune	autoimmune	ADJ
iajs-3516	186	40	diseases	disease	NOUN
iajs-3516	186	41	.	.	PUNCT
iajs-3516	187	1	medicina	medicina	PROPN
iajs-3516	187	2	.	.	PUNCT
iajs-3516	188	1	2025	2025	NUM
iajs-3516	188	2	;	;	PUNCT
iajs-3516	188	3	61(7):1148	61(7):1148	NUM
iajs-3516	188	4	.	.	PUNCT
iajs-3516	189	1	https://doi.org/10.3390/medicina61071148	https://doi.org/10.3390/medicina61071148	PROPN
iajs-3516	189	2	.	.	PUNCT
iajs-3516	190	1	https://doi.org/10.1016/j.cell.2022.08.026	https://doi.org/10.1016/j.cell.2022.08.026	PROPN
iajs-3516	190	2	https://doi.org/10.1542/peds.2008-1879	https://doi.org/10.1542/peds.2008-1879	PROPN
iajs-3516	190	3	https://doi.org/10.1542/peds.2008-1879	https://doi.org/10.1542/peds.2008-1879	PROPN
iajs-3516	190	4	https://doi.org/10.1186/s12985-023-02187-9	https://doi.org/10.1186/s12985-023-02187-9	NUM
iajs-3516	190	5	https://doi.org/10.3390/biom11091380	https://doi.org/10.3390/biom11091380	NOUN
iajs-3516	190	6	https://doi.org/10.1007/s12016-011-8294-7	https://doi.org/10.1007/s12016-011-8294-7	NUM
iajs-3516	190	7	https://doi.org/10.3390/ijms24087407	https://doi.org/10.3390/ijms24087407	INTJ
iajs-3516	190	8	https://doi.org/10.1016/j.ddmod.2020.01.001	https://doi.org/10.1016/j.ddmod.2020.01.001	INTJ
iajs-3516	190	9	https://doi.org/10.1002/cti2.1451	https://doi.org/10.1002/cti2.1451	ADV
iajs-3516	190	10	https://doi.org/10.1016/j.berh.2008.09.007	https://doi.org/10.1016/j.berh.2008.09.007	PROPN
iajs-3516	190	11	https://doi.org/10.3390/medicina61071148	https://doi.org/10.3390/medicina61071148	NOUN